<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Influenza Other Respir Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Influenza Other Respir Viruses</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1750-2659</journal-id><journal-id journal-id-type="publisher-id">IRV</journal-id><journal-title-group><journal-title>Influenza and Other Respiratory Viruses</journal-title></journal-title-group><issn pub-type="ppub">1750-2640</issn><issn pub-type="epub">1750-2659</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6928059</article-id><article-id pub-id-type="doi">10.1111/irv.12670</article-id><article-id pub-id-type="publisher-id">IRV12670</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Influenza and tuberculosis co&#x02010;infection: A systematic review</article-title><alt-title alt-title-type="left-running-head">WALAZA et al.</alt-title></title-group><contrib-group><contrib id="irv12670-cr-0001" contrib-type="author" corresp="yes"><name><surname>Walaza</surname><given-names>Sibongile</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7588-2480</contrib-id><xref ref-type="aff" rid="irv12670-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0002">
<sup>2</sup>
</xref><address><email>sibongilew@nicd.ac.za</email></address></contrib><contrib id="irv12670-cr-0002" contrib-type="author" corresp="yes"><name><surname>Cohen</surname><given-names>Cheryl</given-names></name><xref ref-type="aff" rid="irv12670-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0002">
<sup>2</sup>
</xref><address><email>cherylc@nicd.ac.za</email></address></contrib><contrib id="irv12670-cr-0003" contrib-type="author"><name><surname>Tempia</surname><given-names>Stefano</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4395-347X</contrib-id><xref ref-type="aff" rid="irv12670-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="irv12670-cr-0004" contrib-type="author"><name><surname>Moyes</surname><given-names>Jocelyn</given-names></name><xref ref-type="aff" rid="irv12670-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="irv12670-cr-0005" contrib-type="author"><name><surname>Nguweneza</surname><given-names>Athermon</given-names></name><xref ref-type="aff" rid="irv12670-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="irv12670-cr-0006" contrib-type="author"><name><surname>Madhi</surname><given-names>Shabir A.</given-names></name><xref ref-type="aff" rid="irv12670-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0005">
<sup>5</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="irv12670-cr-0007" contrib-type="author"><name><surname>McMorrow</surname><given-names>Meredith</given-names></name><xref ref-type="aff" rid="irv12670-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0004">
<sup>4</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="irv12670-cr-0008" contrib-type="author"><name><surname>Cohen</surname><given-names>Adam L.</given-names></name><xref ref-type="aff" rid="irv12670-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0004">
<sup>4</sup>
</xref><xref ref-type="aff" rid="irv12670-aff-0008">
<sup>8</sup>
</xref></contrib></contrib-group><aff id="irv12670-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Centre for Respiratory Diseases and Meningitis</named-content>
<institution>National Institute for Communicable Diseases of the National Health Laboratory Service</institution>
<city>Johannesburg</city>
<country country="ZA">South Africa</country>
</aff><aff id="irv12670-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">School of Public Health, Faculty of Health Sciences</named-content>
<institution>University of the Witwatersrand</institution>
<city>Johannesburg</city>
<country country="ZA">South Africa</country>
</aff><aff id="irv12670-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Influenza Division</named-content>
<institution>Centers for Disease Control and Prevention</institution>
<city>Atlanta</city>
<named-content content-type="country-part">GA</named-content>
<country country="US">USA</country>
</aff><aff id="irv12670-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Influenza Program</named-content>
<institution>Centers for Disease Control and Prevention</institution>
<city>Pretoria</city>
<country country="ZA">South Africa</country>
</aff><aff id="irv12670-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Medical Research Council, Respiratory and Meningeal Pathogens Research Unit</named-content>
<institution>University of the Witwatersrand</institution>
<city>Johannesburg</city>
<country country="ZA">South Africa</country>
</aff><aff id="irv12670-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases</named-content>
<institution>University of the Witwatersrand</institution>
<city>Johannesburg</city>
<country country="ZA">South Africa</country>
</aff><aff id="irv12670-aff-0007">
<label><sup>7</sup></label>
<institution>U.S. Public Health Service</institution>
<city>Rockville</city>
<named-content content-type="country-part">MD</named-content>
<country country="US">USA</country>
</aff><aff id="irv12670-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Global Immunization Monitoring and Surveillance, Expanded Programme on Immunization Department of Immunization</named-content>
<institution>Vaccines and Biologicals World Health Organization</institution>
<city>Geneva</city>
<country country="CH">Switzerland</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Sibongile Walaza and Cheryl Cohen, Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Private Bag X4, Sandringham, 2131, Gauteng, South Africa.<break/>
Emails: <email>sibongilew@nicd.ac.za</email> (S.W.); <email>cherylc@nicd.ac.za</email> (C.C.)<break/></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2020</year></pub-date><volume>14</volume><issue>1</issue><issue-id pub-id-type="doi">10.1111/irv.v14.1</issue-id><fpage>77</fpage><lpage>91</lpage><history><date date-type="received"><day>09</day><month>10</month><year>2018</year></date><date date-type="rev-recd"><day>26</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2019</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 John Wiley & Sons Ltd <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2019 The Authors. <italic>Influenza and Other Respiratory Viruses</italic> Published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:IRV-14-77.pdf"/><abstract id="irv12670-abs-0001"><title>Abstract</title><sec id="irv12670-sec-0001"><title>Introduction</title><p>There are limited data on risk of severe disease or outcomes in patients with influenza and pulmonary tuberculosis (PTB) co&#x02010;infection compared to those with single infection.</p></sec><sec id="irv12670-sec-0002"><title>Methods</title><p>We conducted a systematic review of published literature on the interaction of influenza viruses and PTB. Studies were eligible for inclusion if they presented data on prevalence, disease association, presentation or severity of laboratory&#x02010;confirmed influenza among clinically diagnosed or laboratory&#x02010;confirmed PTB cases. We searched eight databases from inception until December 2018. Summary characteristics of each study were extracted, and a narrative summary was presented. Cohort or case&#x02010;control studies were assessed for potential bias using the Newcastle&#x02010;Ottawa scale.</p></sec><sec id="irv12670-sec-0003"><title>Results</title><p>We assessed 5154 abstracts, reviewed 146 manuscripts and included 19 studies fulfilling selection criteria (13 human and six animal). Of seven studies reporting on the possible effect of the underlying PTB disease in patients with influenza, three of four analytical studies reported no association with disease severity of influenza infection in those with PTB, whilst one study reported PTB as a risk factor for influenza&#x02010;associated hospitalization.</p><p>An association between influenza infection and PTB disease was found in three of five analytical studies; whereas the two other studies reported a high frequency of PTB disease progression and complications among patients with seasonal influenza co&#x02010;infection.</p></sec><sec id="irv12670-sec-0004"><title>Conclusion</title><p>Human analytical studies of an association between co&#x02010;infection and severe influenza&#x02010; or PTB&#x02010;associated disease or increased prevalence of influenza co&#x02010;infection in individuals' hospitalized for PTB were not conclusive. Data are limited from large, high&#x02010;quality, analytical epidemiological studies with laboratory&#x02010;confirmed endpoints.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="irv12670-kwd-0001">influenza</kwd><kwd id="irv12670-kwd-0002">interaction</kwd><kwd id="irv12670-kwd-0003">tuberculosis</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="15"/><word-count count="8923"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.3 mode:remove_FC converted:23.12.2019</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="irv12670-cit-1001">
<string-name>
<surname>Walaza</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Influenza and tuberculosis co&#x02010;infection: A systematic review</article-title>. <source xml:lang="en">Influenza Other Respi Viruses</source>. <year>2020</year>;<volume>14</volume>:<fpage>77</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1111/irv.12670</pub-id>
</mixed-citation>
</p></notes></front><body id="irv12670-body-0001"><sec id="irv12670-sec-0005"><label>1</label><title>INTRODUCTION</title><p>Influenza virus infections cause substantial annual morbidity and mortality in humans worldwide.<xref rid="irv12670-bib-0001" ref-type="ref">1</xref>, <xref rid="irv12670-bib-0002" ref-type="ref">2</xref>, <xref rid="irv12670-bib-0003" ref-type="ref">3</xref> Globally, it is estimated that annual influenza epidemics result in three to five million cases of severe illness and between 290&#x000a0;000 and 650&#x000a0;000 influenza&#x02010;associated respiratory deaths.<xref rid="irv12670-bib-0004" ref-type="ref">4</xref>, <xref rid="irv12670-bib-0005" ref-type="ref">5</xref> In 2015, there were an estimated 10.4 million incident cases of tuberculosis and 1.8 million tuberculosis deaths globally.<xref rid="irv12670-bib-0006" ref-type="ref">6</xref> In 2015, tuberculosis was the most common cause of infectious disease&#x02010;related deaths worldwide, with the majority of cases reported in Asia and Africa.<xref rid="irv12670-bib-0006" ref-type="ref">6</xref>
</p><p>Both influenza and tuberculosis impair host immune responses. Specifically, influenza can impair T&#x02010;cell immunity and weaken innate immune responses against secondary bacterial infections.<xref rid="irv12670-bib-0007" ref-type="ref">7</xref>, <xref rid="irv12670-bib-0008" ref-type="ref">8</xref>, <xref rid="irv12670-bib-0009" ref-type="ref">9</xref>, <xref rid="irv12670-bib-0010" ref-type="ref">10</xref>, <xref rid="irv12670-bib-0011" ref-type="ref">11</xref>, <xref rid="irv12670-bib-0012" ref-type="ref">12</xref> Lethal synergism associated with viral and bacterial infections can result in increased risk of influenza&#x02010;associated mortality.<xref rid="irv12670-bib-0013" ref-type="ref">13</xref> Furthermore, individuals with pulmonary tuberculosis (PTB) may be at increased risk for severe influenza disease and death due to chronic lung disease and immunosupression. Ecological studies and mathematical modelling of epidemiologic data suggest an increase in the frequency of influenza disease or severe influenza&#x02010;associated disease in individuals with PTB during influenza pandemics<xref rid="irv12670-bib-0014" ref-type="ref">14</xref>, <xref rid="irv12670-bib-0015" ref-type="ref">15</xref>, <xref rid="irv12670-bib-0016" ref-type="ref">16</xref>, <xref rid="irv12670-bib-0017" ref-type="ref">17</xref>, <xref rid="irv12670-bib-0018" ref-type="ref">18</xref> or during seasonal influenza epidemics<xref rid="irv12670-bib-0019" ref-type="ref">19</xref> compared with otherwise healthy individuals.</p><p>Influenza infection may facilitate the progression of latent <italic>Mycobacterium tuberculosis</italic> infection to tuberculosis disease and alter the clinical presentation of tuberculosis.<xref rid="irv12670-bib-0020" ref-type="ref">20</xref> It is also possible that influenza infection may exacerbate PTB.</p><p>Whilst chronic lung diseases are a known risk factor for severe outcomes due to influenza infection and influenza vaccination is recommended in this group, PTB is not listed as a separate priority group.<xref rid="irv12670-bib-0021" ref-type="ref">21</xref> Understanding the interaction between influenza and PTB may assist in determining whether individuals with PTB should be prioritized for influenza vaccination and treatment with antiviral medications. We conducted a systematic review of published literature on the association between laboratory&#x02010;confirmed influenza and PTB, that is influenza in individuals with tuberculosis and tuberculosis in individuals with influenza infection, in order to summarize whether co&#x02010;infection affects presentation, progression or disease outcome.</p></sec><sec sec-type="methods" id="irv12670-sec-0006"><label>2</label><title>METHODS</title><p>We conducted a systematic review, which is reported in accordance with PRISMA guidelines,<xref rid="irv12670-bib-0022" ref-type="ref">22</xref> to summarize whether individuals with co&#x02010;infection present with severe influenza or PTB disease as compared to those with single infection or disease. Burden, transmission and severity of co&#x02010;infection were included for completeness.</p><sec id="irv12670-sec-0007"><label>2.1</label><title>Eligibility and inclusion criteria</title><p>This review was restricted to published abstracts and articles from inception to December 2018 that reported data on the association (burden of disease, transmission and severity) between laboratory&#x02010;confirmed influenza and clinically diagnosed or laboratory&#x02010;confirmed PTB. Due to the scarcity of published data, descriptive studies, including studies without comparison groups, were included. Articles that included seasonal or pandemic influenza and animal experimental studies were also included. For human studies, inclusion was limited to studies in which influenza was laboratory&#x02010;confirmed and tuberculosis included PTB. Animal studies were included as they may provide useful insights into possible underlying mechanisms of interactions in humans. Studies that modelled ecological data on the association between influenza and tuberculosis, individual case reports, vaccine studies and influenza antiviral therapy in patients with tuberculosis were not included. Study selection is summarized in Figure <xref rid="irv12670-fig-0001" ref-type="fig">1</xref>.</p><fig fig-type="Figure" xml:lang="en" id="irv12670-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow diagram for systematic review of influenza and tuberculosis co&#x02010;infection</p></caption><graphic id="nlm-graphic-1" xlink:href="IRV-14-77-g001"/></fig></sec><sec id="irv12670-sec-0008"><label>2.2</label><title>Search strategy</title><p>We conducted a systematic review of the scientific literature identified through searches using online databases. For our search, we included terms for influenza (&#x0201c;influenza&#x0201d; or &#x0201c;flu&#x0201d; or &#x0201c;influenza virus&#x0201d; or &#x0201c;human influenza&#x0201d;) and for tuberculosis (&#x0201c;tuberculosis&#x0201d; or &#x0201c;TB&#x0201d;). The Medline, Embase, PsycINFO, CINAHL, Web of Science, Cochrane, CAB Abstracts and Global Health databases were searched. The search strategy, which was completed in consultation with a research librarian, differed slightly by database (Appendix <xref rid="irv12670-sup-0001" ref-type="supplementary-material">S1</xref>). In addition, bibliographies of papers that were reviewed were checked for further relevant publications. The search was restricted to articles published in English, French, Italian, German, Russian, Finish, Japanese or Portuguese.</p></sec><sec id="irv12670-sec-0009"><label>2.3</label><title>Study selection</title><p>Literature search results (titles and abstracts) were screened independently by two authors (SW and one of the co&#x02010;authors: CC, AN, JM, ALC or MM) to identify all citations that possibly met the inclusion criteria. Full manuscripts of selected citations were retrieved and assessed by one reviewer (SW) against the inclusion/exclusion criteria and checked independently by a second reviewer, one of the co&#x02010;authors (ALC, MM, JM, AN, CC, ST). Additional articles were identified from reviewing bibliographies of published articles. Discrepancies in included articles were resolved by consensus between the two reviewers with involvement of a third reviewer (CC) where necessary. Animal experimental studies, descriptive and analytic studies in humans were included. Studies that reported data on the association between laboratory&#x02010;confirmed influenza and clinically diagnosed or laboratory&#x02010;confirmed PTB including the following were included:
<list list-type="bullet" id="irv12670-list-0001"><list-item><p>Prevalence and risk for influenza&#x02010;associated severe disease among patients with PTB disease;</p></list-item><list-item><p>Prevalence and risk for PTB&#x02010;associated severe disease among patients with influenza infection;</p></list-item><list-item><p>Effect of influenza on PTB disease progression</p></list-item><list-item><p>Clinical presentation of influenza and PTB co&#x02010;infection; and</p></list-item><list-item><p>Immune response to co&#x02010;infection, presentation or outcome of influenza&#x02010;tuberculosis co&#x02010;infection in animal studies.</p></list-item></list>
</p></sec><sec id="irv12670-sec-0010"><label>2.4</label><title>Data extraction and synthesis</title><p>Data extracted from each study were entered into a Microsoft Excel worksheet, including: year published, study design, type of study (descriptive vs analytical), location of study, period of study, sample size, study setting (hospital/ICU/outpatient), type of influenza testing, tuberculosis testing method (microscopy, culture, polymerase chain reaction [PCR]), results (influenza and tuberculosis), influenza strains, outcome and findings. In studies where only a number of cases or percentage was reported, we calculated the counterpart for the review. We summarized data under two groups, PTB in patients with influenza and influenza in patients with PTB; this was decided after examination of data. We did not stratify by age, gender or other characteristics.</p><p>Individual studies were independently assessed for potential bias or confounding. When studies used either cohort or case&#x02010;control designs, we used the Newcastle&#x02010;Ottawa Scale to rate the quality of the included papers.<xref rid="irv12670-bib-0023" ref-type="ref">23</xref> Studies were considered high quality if the Newcastle&#x02010;Ottawa Scale was &#x02265;7 out of 9 and were considered of low quality if the score was &#x02264;3 out of 9. Study methods differed; summary measures (odds ratios, relative risks), when reported, were abstracted. Data synthesis consisted of reporting the key findings of the different studies. Where possible the studies were classified according to whether they fall among the 22 high tuberculosis burden countries (HBC) that account for aproximately. 80% of world's tuberculosis cases.<xref rid="irv12670-bib-0003" ref-type="ref">3</xref> Review protocol attached (Appendix <xref rid="irv12670-sup-0002" ref-type="supplementary-material">S2</xref>).</p></sec><sec id="irv12670-sec-0011"><label>2.5</label><title>Ethics</title><p>Since this study used published data, it was exempt from human subjects ethics review.</p></sec></sec><sec sec-type="results" id="irv12670-sec-0012"><label>3</label><title>RESULTS</title><p>The search identified 5752 records; 598 of these were duplicates and were removed. Seven additional records were identified through other sources (Figure <xref rid="irv12670-fig-0001" ref-type="fig">1</xref>). The remaining 5154 titles and abstracts were screened. Of these, 146 articles were identified for full review, and 19 articles met the inclusion criteria. Of these, 13 were in humans and six were animal experimental studies.</p><sec id="irv12670-sec-0013"><label>3.1</label><title>Human studies</title><p>Of the 13 human studies, 10 used real&#x02010;time reverse transcription polymerase chain reaction (RT&#x02010;PCR) and three used unpaired serology to test for influenza infection. A total of 27&#x000a0;566 individuals (range 19<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>&#x02010;12&#x000a0;196<xref rid="irv12670-bib-0025" ref-type="ref">25</xref>) were included in human studies, 12&#x000a0;777 (range 31<xref rid="irv12670-bib-0026" ref-type="ref">26</xref> to 12&#x000a0;196<xref rid="irv12670-bib-0025" ref-type="ref">25</xref>) in descriptive and 14&#x000a0;789 (range 19<xref rid="irv12670-bib-0024" ref-type="ref">24</xref> to 3646<xref rid="irv12670-bib-0027" ref-type="ref">27</xref>) in analytical studies (Tables <xref rid="irv12670-tbl-0001" ref-type="table">1</xref> and <xref rid="irv12670-tbl-0002" ref-type="table">2</xref>). Eight of the human studies were analytical.<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>, <xref rid="irv12670-bib-0027" ref-type="ref">27</xref>, <xref rid="irv12670-bib-0028" ref-type="ref">28</xref>, <xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref>, <xref rid="irv12670-bib-0031" ref-type="ref">31</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref>, <xref rid="irv12670-bib-0033" ref-type="ref">33</xref> Eight studies had laboratory&#x02010;confirmed results for both influenza and tuberculosis (Tables <xref rid="irv12670-tbl-0001" ref-type="table">1</xref> and <xref rid="irv12670-tbl-0002" ref-type="table">2</xref>). Nine studies were from high burden countries including six from Africa. In addition, three studies from Europe reported data from a period (1952&#x02010;1963) with high tuberculosis prevalence. Three of the eight analytical studies were of high quality. Six studies reported on PTB disease in individuals with influenza,<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>, <xref rid="irv12670-bib-0025" ref-type="ref">25</xref>, <xref rid="irv12670-bib-0027" ref-type="ref">27</xref>, <xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0034" ref-type="ref">34</xref>, <xref rid="irv12670-bib-0035" ref-type="ref">35</xref> six on influenza in individuals with the underlying PTB<xref rid="irv12670-bib-0026" ref-type="ref">26</xref>, <xref rid="irv12670-bib-0028" ref-type="ref">28</xref>, <xref rid="irv12670-bib-0031" ref-type="ref">31</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref>, <xref rid="irv12670-bib-0033" ref-type="ref">33</xref>, <xref rid="irv12670-bib-0036" ref-type="ref">36</xref> and one on both (Tables <xref rid="irv12670-tbl-0001" ref-type="table">1</xref> and <xref rid="irv12670-tbl-0002" ref-type="table">2</xref>).<xref rid="irv12670-bib-0030" ref-type="ref">30</xref>
</p><table-wrap id="irv12670-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of studies reporting on effect of tuberculosis in individuals with influenza</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Study</th><th align="left" valign="top" rowspan="1" colspan="1">Country</th><th align="left" valign="top" rowspan="1" colspan="1">Year</th><th align="left" valign="top" rowspan="1" colspan="1">Descriptive/ analytical</th><th align="left" valign="top" rowspan="1" colspan="1">Objective/hypothesis</th><th align="left" valign="top" rowspan="1" colspan="1">Setting</th><th align="left" valign="top" rowspan="1" colspan="1">Number studied</th><th align="left" valign="top" rowspan="1" colspan="1">Influenza type</th><th align="left" valign="top" rowspan="1" colspan="1">Laboratory&#x02010;confirmed influenza</th><th align="left" valign="top" rowspan="1" colspan="1">TB diagnosis</th><th align="left" valign="top" rowspan="1" colspan="1">Findings</th><th align="left" valign="top" rowspan="1" colspan="1">Association<xref ref-type="fn" rid="irv12670-note-0002">a</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Newcastle&#x02010;Ottawa Score<xref ref-type="fn" rid="irv12670-note-0003">b</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Archer, (2009)<xref rid="irv12670-bib-0034" ref-type="ref">34</xref>
</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">Descriptive</td><td align="left" rowspan="1" colspan="1">Describe epidemiology of lab&#x02010;confirmed pandemic influenza cases in South Africa</td><td align="left" rowspan="1" colspan="1">Hospital admissions</td><td align="left" rowspan="1" colspan="1">72 cases</td><td align="left" rowspan="1" colspan="1">Pandemic A(H1N1)2009</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">Lab methods not specified as diagnosed/ reported by attending clinician</td><td align="left" rowspan="1" colspan="1">7/72 (10%) cases who died with influenza A(H1N1)pdm09 had TB vs 1% TB prevalence in 2006 in general community. Not evaluated statistically</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Puvanaligam (2011)<xref rid="irv12670-bib-0035" ref-type="ref">35</xref>
</td><td align="left" rowspan="1" colspan="1">India</td><td align="left" rowspan="1" colspan="1">2009&#x02010; 2010</td><td align="left" rowspan="1" colspan="1">Descriptive</td><td align="left" rowspan="1" colspan="1">Describe clinical profile of H1N1 cases</td><td align="left" rowspan="1" colspan="1">Hospital admissions</td><td align="left" rowspan="1" colspan="1">442 cases</td><td align="left" rowspan="1" colspan="1">Pandemic A(H1N1)2009</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR/culture</td><td align="left" rowspan="1" colspan="1">Not specified</td><td align="left" rowspan="1" colspan="1">8.8% influenza A (H1N1)pdm09 cases had TB vs 0.4% TB prevalence in general population (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.001)</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Abadom<xref rid="irv12670-bib-0027" ref-type="ref">27</xref>
</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">2009&#x02010;2012</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Assessed risk factors for influenza&#x02010;associated SARI hospitalization</td><td align="left" rowspan="1" colspan="1">Hospital admission</td><td align="left" rowspan="1" colspan="1">3646</td><td align="left" rowspan="1" colspan="1">Seasonal and pandemic</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">Microscopy, <italic>M&#x000a0;tuberculosis</italic> culture/XPert MTB/RIF</td><td align="left" rowspan="1" colspan="1">
<p>TB was a risk factor for influenza&#x02010;associated hospitalization (CPR 1.85, 95%CI 1.68&#x02010;2.02)</p>
<p>Covariates adjusted for: history of smoking (CPR 3.8, 95% CI 3.5&#x02010;4.16); HIV (CPR 3.61, 95% CI 3.5&#x02010;3.71; admission in past 12&#x000a0;mo (CPR 2.07, 95% CI 1.92&#x02010;2.23), age, 3rd dose &#x000a0;of pneumococcal&#x000a0;vaccine in &#x0003c;5&#x000a0;y&#x000a0;(CPR 0.74,&#x000a0;95%&#x000a0;CI&#x000a0;0.741&#x02010;0.7.0).</p>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Noh (2013)<xref rid="irv12670-bib-0025" ref-type="ref">25</xref>
</td><td align="left" rowspan="1" colspan="1">South Korea</td><td align="left" rowspan="1" colspan="1">2009&#x02010; 2011</td><td align="left" rowspan="1" colspan="1">Descriptive</td><td align="left" rowspan="1" colspan="1">Describe cases with concurrent TB and influenza</td><td align="left" rowspan="1" colspan="1">Hospital admissions</td><td align="left" rowspan="1" colspan="1">12&#x000a0;196 subjects</td><td align="left" rowspan="1" colspan="1">Pandemic A(H1N1) 2009</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">Auramine stain, TB PCR and TB culture</td><td align="left" rowspan="1" colspan="1">No deaths in the 7 cases of concurrent influenza&#x02010;TB infection. Not evaluated statistically</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Ope (2011)<xref rid="irv12670-bib-0029" ref-type="ref">29</xref>
</td><td align="left" rowspan="1" colspan="1">Kenya</td><td align="left" rowspan="1" colspan="1">2007&#x02010;2009</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Describe risk factors for influenza hospitalization</td><td align="left" rowspan="1" colspan="1">Hospital admissions</td><td align="left" rowspan="1" colspan="1">64 cases; 190 controls</td><td align="left" rowspan="1" colspan="1">Seasonal (AH3N2 &#x00026;A H1N1 &#x00026; B)</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">Self&#x02010;report verified by clinician diagnosis and medication</td><td align="left" rowspan="1" colspan="1">
<p>TB associated with influenza hospitalization on bivariate (OR 12.0, 95% CI 1.3&#x02010;107.37) but not on multivariate (aOR not presented) analysis</p>
<p>Adjusted for chronic lung disease, chronic heart disease, HIV infection, owns cattle and number of chickens owned.</p>
<p>HIV&#x02010;infected more likely to be hospitalized for influenza [aOR3.56 (95% CI 1.25&#x02010;10.07)]</p>
</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">Roth (2013)<xref rid="irv12670-bib-0030" ref-type="ref">30</xref>
</td><td align="left" rowspan="1" colspan="1">Thailand</td><td align="left" rowspan="1" colspan="1">2003&#x02010;2011</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Compare characteristics of TB/influenza to influenza and TB only</td><td align="left" rowspan="1" colspan="1">Hospital admissions</td><td align="left" rowspan="1" colspan="1">7180 subjects</td><td align="left" rowspan="1" colspan="1">Seasonal &#x00026; pandemic (AH1N1) 2009</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">AFB&#x000a0;&#x000b1;&#x000a0;culture</td><td align="left" rowspan="1" colspan="1">
<p>Influenza&#x02010;TB co&#x02010;infection not associated with increased severity/mortality. Deaths in 0/23 co&#x02010;infected vs 17/604 (2.8%) with influenza only (<italic>P</italic>&#x000a0;=&#x000a0;1.0)</p>
<p>HIV prevalence among co&#x02010;infected 3/18 (17%)</p>
</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Koegelenberg, (2009)<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>
</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Describe epidemiological characteristics, clinical features and outcome of pandemic H1N1 cases complicated by respiratory failure</td><td align="left" rowspan="1" colspan="1">Intensive care unit admissions</td><td align="left" rowspan="1" colspan="1">19 cases</td><td align="left" rowspan="1" colspan="1">Pandemic A(H1N1) 2009</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">Lab methods not specified&#x02010;presence/absence of disease</td><td align="left" rowspan="1" colspan="1">4/19 ICU cases with influenza A(H1N1)pdm09 had TB. TB in 4/13 (31%) who died vs 0/6 who survived, (<italic>P</italic>&#x000a0;=&#x000a0;.5)</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">6</td></tr></tbody></table><table-wrap-foot id="irv12670-ntgp-0001"><fn id="irv12670-note-0001"><p>Abbreviations: AFB, acid&#x02010;fast bacilli; AOR, adjusted odds ratio; CPR: case&#x02010;population ratio; lab, laboratory; NA, not applicable; OR, odds ratio; RT&#x02010;PCR, real&#x02010;time reverse transcriptase polymerase chain reaction; SARI, severe acute respiratory illness; TB, tuberculosis; USA, United States of America.</p></fn><fn id="irv12670-note-0002"><label>a</label><p>Association&#x02014;Evidence of/or association (univariate/multivariable analysis) with increased severity of influenza disease in those with vs without tuberculosis; or prevalence of co&#x02010;infection in those with severe influenza disease.</p></fn><fn id="irv12670-note-0003"><label>b</label><p>Score out of a possible score of 9.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="irv12670-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Summary of studies reporting on the effect of influenza in individuals with tuberculosis (TB)</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Study</th><th align="left" valign="top" rowspan="1" colspan="1">Country</th><th align="left" valign="top" rowspan="1" colspan="1">Year</th><th align="left" valign="top" rowspan="1" colspan="1">Descriptive/ analytical</th><th align="left" valign="top" rowspan="1" colspan="1">Objective/hypothesis</th><th align="left" valign="top" rowspan="1" colspan="1">Setting</th><th align="left" valign="top" rowspan="1" colspan="1">Number studied</th><th align="left" valign="top" rowspan="1" colspan="1">Influenza type</th><th align="left" valign="top" rowspan="1" colspan="1">Laboratory&#x02010;confirmed influenza</th><th align="left" valign="top" rowspan="1" colspan="1">TB diagnosis</th><th align="left" valign="top" rowspan="1" colspan="1">Findings</th><th align="left" valign="top" rowspan="1" colspan="1">Association<xref ref-type="fn" rid="irv12670-note-0005">a</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Newcastle&#x02010;Ottawa Score<xref ref-type="fn" rid="irv12670-note-0006">b</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Dijkman (1967)<xref rid="irv12670-bib-0026" ref-type="ref">26</xref>
</td><td align="left" rowspan="1" colspan="1">Netherlands</td><td align="left" rowspan="1" colspan="1">1957&#x02010;1963</td><td align="left" rowspan="1" colspan="1">Descriptive</td><td align="left" rowspan="1" colspan="1">Investigated association between acute respiratory infection (influenza) and unfavourable course of primary pulmonary and hilar tuberculosis among children&#x02010;</td><td align="left" rowspan="1" colspan="1">Tuberculosis sanatorium</td><td align="left" rowspan="1" colspan="1">36 subjects</td><td align="left" rowspan="1" colspan="1">Seasonal, influenza A &#x00026; B</td><td align="left" rowspan="1" colspan="1">Serology, HI antibodies against influenza A. &#x02265;fourfold increase in antibody titres</td><td align="left" rowspan="1" colspan="1">Clinical&#x00026; radiological examination AFB towards end of hospitalization</td><td align="left" rowspan="1" colspan="1">20% (5/20) of paediatric patients with influenza developed segmental pulmonary lesions. Not evaluated statistically</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Sellers (1959)<xref rid="irv12670-bib-0036" ref-type="ref">36</xref>
</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">1957</td><td align="left" rowspan="1" colspan="1">Descriptive</td><td align="left" rowspan="1" colspan="1">Assess effect of superimposed viral infection on existing TB</td><td align="left" rowspan="1" colspan="1">TB sanatorium</td><td align="left" rowspan="1" colspan="1">31&#x000a0;subjects</td><td align="left" rowspan="1" colspan="1">Pandemic, influenza A, 1957</td><td align="left" rowspan="1" colspan="1">HI antibodies to PR8 type A &#x00026; FMI type A</td><td align="left" rowspan="1" colspan="1">
<italic>Tuberculin</italic> conversion, X&#x02010;ray changes&#x000a0;&#x000b1;&#x000a0;<italic>M&#x000a0;tuberculosis</italic> culture</td><td align="left" rowspan="1" colspan="1">2/31&#x000a0;TB cases with influenza had signs of worsening on X&#x02010;ray (increased perihilar nodes, increased infiltration around cavity and increase in cavity)</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Walaza (2015)<xref rid="irv12670-bib-0032" ref-type="ref">32</xref>
</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">2010&#x02010;2011</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Compare influenza single infection &#x00026; influenza&#x02010;TB co&#x02010;infection to TB single infection</td><td align="left" rowspan="1" colspan="1">Hospital admission</td><td align="left" rowspan="1" colspan="1">2959&#x000a0;subjects</td><td align="left" rowspan="1" colspan="1">Seasonal</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR</td><td align="left" rowspan="1" colspan="1">Microscopy, <italic>M&#x000a0;tuberculosis</italic> culture/XPert MTB/RIF</td><td align="left" rowspan="1" colspan="1">
<p>Increased risk of death in cases with co&#x02010;infection vs TB only, aRRR 3.1, 95% CI 1.1&#x02010;10.1. Increased risk of death in co&#x02010;infected vs TB only with symptoms &#x02265;7&#x000a0;d, aRRR 5.5, 95%CI 1.2&#x02010;25.3</p>
<p>Adjusted for age, site, HIV status, duration of symptoms, TB treatment, antibiotic therapy, ICU admission, duration of hospitalization</p>
<p>HIV infection in TB only vs co&#x02010;infected aRRR 1.6 (0.5&#x02010;4.9)</p>
</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">Espersen (1954)<xref rid="irv12670-bib-0028" ref-type="ref">28</xref>
</td><td align="left" rowspan="1" colspan="1">Denmark</td><td align="left" rowspan="1" colspan="1">1952</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Describe the epidemic of influenza B in a TB sanatorium</td><td align="left" rowspan="1" colspan="1">Tuberculosis sanatorium</td><td align="left" rowspan="1" colspan="1">295 subjects</td><td align="left" rowspan="1" colspan="1">Seasonal, influenza B</td><td align="left" rowspan="1" colspan="1">HI</td><td align="left" rowspan="1" colspan="1">Clinical, TB smear&#x000a0;&#x000b1;&#x000a0;culture</td><td align="left" rowspan="1" colspan="1">Radiological changes or sputum conversion in 7/53 (13%) co&#x02010;infected vs 3/142 (2%) TB only (<italic>P</italic>&#x000a0;=&#x000a0;.005)</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Dube (2016)<xref rid="irv12670-bib-0033" ref-type="ref">33</xref>
</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">2011&#x02010;2012</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Compare prevalence of influenza in children with definite TB to unlikely TB</td><td align="left" rowspan="1" colspan="1">Hospital admission</td><td align="left" rowspan="1" colspan="1">214 suspected TB (34 definite TB, 94 Unlikely TB, 86 unconfirmed TB)</td><td align="left" rowspan="1" colspan="1">Seasonal</td><td align="left" rowspan="1" colspan="1">Multiplex PCR</td><td align="left" rowspan="1" colspan="1">
<italic>M&#x000a0;tuberculosis</italic> culture/XPert MTB/RIF</td><td align="left" rowspan="1" colspan="1">Influenza C 18% (6/34) vs 4% (4/94), <italic>P</italic>&#x000a0;=&#x000a0;.04</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">De Paus (2013)<xref rid="irv12670-bib-0031" ref-type="ref">31</xref>
</td><td align="left" rowspan="1" colspan="1">Indonesia</td><td align="left" rowspan="1" colspan="1">2001&#x02010;2004</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Did newly diagnosed TB patients have a recent influenza virus infection? Hypothesis&#x02014;Influenza virus enhanced the susceptibility to develop active TB/ reactivated latent TB</td><td align="left" rowspan="1" colspan="1">Cases from tuberculosis clinic and community controls</td><td align="left" rowspan="1" colspan="1">111&#x000a0;TB cases; 111 community controls, matched for age, sex and socio&#x02010;economic status</td><td align="left" rowspan="1" colspan="1">Seasonal (AH3N2/AH1N1)</td><td align="left" rowspan="1" colspan="1">
<p>Serology HI&#x02010;IG and IGM antibodies against influenza A</p>
<p>HI titre &#x02265;10</p>
</td><td align="left" rowspan="1" colspan="1">WHO case definition (clinical&#x000a0;+&#x000a0;CXR changes positive microscopy and culture for Mtb)</td><td align="left" rowspan="1" colspan="1">Prevalence of influenza antibodies among TB cases vs controls was 46% vs 41% (<italic>P</italic>&#x000a0;=&#x000a0;.5) for A/H1N1pdm09 and 82% vs 82% (<italic>P</italic>&#x000a0;=&#x000a0;1.0) for A/H3N2</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">Roth (2013)<xref rid="irv12670-bib-0030" ref-type="ref">30</xref>
</td><td align="left" rowspan="1" colspan="1">Thailand</td><td align="left" rowspan="1" colspan="1">2003&#x02010;2011</td><td align="left" rowspan="1" colspan="1">Analytical</td><td align="left" rowspan="1" colspan="1">Compare characteristics of TB/influenza to influenza and TB only</td><td align="left" rowspan="1" colspan="1">Hospital admissions</td><td align="left" rowspan="1" colspan="1">7180 subjects</td><td align="left" rowspan="1" colspan="1">Seasonal and pandemic</td><td align="left" rowspan="1" colspan="1">RT&#x02010;PCR/serology</td><td align="left" rowspan="1" colspan="1">&#x02265;1 sputum AFB or culture positive</td><td align="left" rowspan="1" colspan="1">Death in 0/23 cases with co&#x02010;infection vs 30/646 (4.6%) in cases with TB only, <italic>P</italic>&#x000a0;=&#x000a0;.6</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">6</td></tr></tbody></table><table-wrap-foot id="irv12670-ntgp-0002"><fn id="irv12670-note-0004"><p>Abbreviations: aRRR, adjusted relative risk ratio; CI, confidence interval; CPR, case&#x02010;population ratio; NA, not applicable; TB, tuberculosis; USA, United States of America.</p></fn><fn id="irv12670-note-0005"><label>a</label><p>Association&#x02014;Evidence of/or association (univariate/multivariable analysis) with increased severity of tuberculous disease in those with vs without influenza; or increased frequency of co&#x02010;infection vs single infection in those with severe tuberculosis disease.</p></fn><fn id="irv12670-note-0006"><label>b</label><p>Score out of a possible score of 9.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="irv12670-sec-0014"><label>3.2</label><title>The effect of PTB in patients with influenza</title><p>Of the seven studies that reported on PTB in individuals with influenza, six were from HBCs (Table <xref rid="irv12670-tbl-0001" ref-type="table">1</xref>)<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>, <xref rid="irv12670-bib-0027" ref-type="ref">27</xref>, <xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref>, <xref rid="irv12670-bib-0034" ref-type="ref">34</xref>, <xref rid="irv12670-bib-0035" ref-type="ref">35</xref> and four were analytical studies.<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>, <xref rid="irv12670-bib-0027" ref-type="ref">27</xref>, <xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref>
</p></sec><sec id="irv12670-sec-0015"><label>3.3</label><title>Descriptive studies</title><p>Three descriptive studies from HBC using data from the 2009 influenza pandemic reported the prevalence of PTB in individuals with influenza. Two of these studies reported a high frequency of tuberculosis (9% and 10%) in cases hospitalized with influenza and among influenza deaths relative to expected community prevalence. However, no inferences could be made on the significance of the association as there were no comparison groups or data were not evaluated statistically.<xref rid="irv12670-bib-0034" ref-type="ref">34</xref>, <xref rid="irv12670-bib-0035" ref-type="ref">35</xref> In a report of individuals that died with influenza A(H1N1)pdm09 virus infection in South Africa, the underlying PTB was identified in seven (10%) of the 72 deaths, which was higher than the 1% general population prevalence in 2006.<xref rid="irv12670-bib-0034" ref-type="ref">34</xref> Similarly, in a hospital&#x02010;based case series of patients positive for influenza A(H1N1)pdm09 virus in India, 9% of influenza cases had PTB compared with 0.4% tuberculosis prevalence in general population (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.001).<xref rid="irv12670-bib-0035" ref-type="ref">35</xref> In a case series of patients infected with influenza A(H1N1)pdm09 virus in South Korea &#x0003c;1% (7/12&#x000a0;196) had newly diagnosed PTB and there were no deaths among the co&#x02010;infected individuals (0/7).<xref rid="irv12670-bib-0025" ref-type="ref">25</xref>
</p></sec><sec id="irv12670-sec-0016"><label>3.4</label><title>Analytical studies</title><p>Three of the four analytical studies were from HBC, including one of high quality that reported no association with severe disease among patients with influenza&#x02010;PTB co&#x02010;infection compared to patients with influenza only.<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>, <xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref> One analytical study reported PTB as a risk factor for influenza&#x02010;associated severe acute respiratory illness (SARI) hospitalization.<xref rid="irv12670-bib-0027" ref-type="ref">27</xref> In this case&#x02010;population study from South Africa, tuberculosis was twice as prevalent among hospitalized influenza&#x02010;associated SARI cases compared with the general South African population (case&#x02010;population ratio [CPR] 1.85, 95%CI 1.68&#x02010;2.02).<xref rid="irv12670-bib-0027" ref-type="ref">27</xref> A case&#x02010;control study from Kenya reported that 6% of hospitalized cases with influenza&#x02010;associated SARI had PTB compared with &#x0003c;1% of neighbourhood&#x02010;matched controls (unadjusted OR 12.0, 95% CI 1.3&#x02010;107.37); however, the underlying PTB was not associated with influenza hospitalization on multivariable analysis.<xref rid="irv12670-bib-0029" ref-type="ref">29</xref> Less than 1% (23/7180) of patients hospitalized for acute respiratory illness and enrolled in a study from Thailand were co&#x02010;infected with influenza viruses and tuberculosis. There were no deaths among the 23 cases with influenza&#x02010;TB co&#x02010;infection, whereas 17 (2.8%) deaths occurred among cases in whom only influenza was identified, <italic>P</italic>&#x000a0;=&#x000a0;.1.<xref rid="irv12670-bib-0030" ref-type="ref">30</xref> In a review of 19 cases with laboratory&#x02010;confirmed influenza A(H1N1)pdm09 virus infection with respiratory failure admitted to an intensive care facility in South Africa, PTB was present in 4/13 (30%) who died vs 0/6 (0%) who survived <italic>P</italic>&#x000a0;=&#x000a0;.5.<xref rid="irv12670-bib-0024" ref-type="ref">24</xref>
</p></sec><sec id="irv12670-sec-0017"><label>3.5</label><title>The effect of influenza in patients with PTB</title><p>Of the seven papers that reported data on influenza in patients with PTB (Table <xref rid="irv12670-tbl-0002" ref-type="table">2</xref>),<xref rid="irv12670-bib-0026" ref-type="ref">26</xref>, <xref rid="irv12670-bib-0028" ref-type="ref">28</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref>, <xref rid="irv12670-bib-0031" ref-type="ref">31</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref>, <xref rid="irv12670-bib-0033" ref-type="ref">33</xref>, <xref rid="irv12670-bib-0036" ref-type="ref">36</xref> four were from tuberculosis HBCs and the other three were from Europe in a period with high tuberculosis prevalence.<xref rid="irv12670-bib-0030" ref-type="ref">30</xref>, <xref rid="irv12670-bib-0031" ref-type="ref">31</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref>, <xref rid="irv12670-bib-0033" ref-type="ref">33</xref> Four of these papers were reported by the authors as analytical studies,<xref rid="irv12670-bib-0030" ref-type="ref">30</xref>, <xref rid="irv12670-bib-0031" ref-type="ref">31</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref>, <xref rid="irv12670-bib-0036" ref-type="ref">36</xref> and a fifth<xref rid="irv12670-bib-0028" ref-type="ref">28</xref> had data suitable for authors of this manuscript to review analytically.</p></sec><sec id="irv12670-sec-0018"><label>3.6</label><title>Descriptive studies</title><p>Two descriptive studies reported on influenza in cases with tuberculosis housed at a sanatorium. Of these, one study described the effect of seasonal influenza on tuberculosis disease progression and complications.<xref rid="irv12670-bib-0026" ref-type="ref">26</xref> This study, from the Netherlands in 1967, among children institutionalized with primary tuberculosis of the lungs and hilar lymphadenopathy reported a high frequency of developing secondary segmental pulmonary lesions, suggesting progression of PTB following serologically diagnosed influenza virus infection (defined as greater than fourfold rise in anti&#x02010;influenza virus antibody titres).<xref rid="irv12670-bib-0026" ref-type="ref">26</xref> The other study in a tuberculosis sanatorium in the United States described the effect of superimposed viral infection on existing tuberculosis following an outbreak of the 1957 influenza A pandemic virus, in which two of 31&#x000a0;TB paediatric cases with influenza infection had evidence of worsening of tuberculosis on chest radiography (Table <xref rid="irv12670-tbl-0002" ref-type="table">2</xref>).<xref rid="irv12670-bib-0036" ref-type="ref">36</xref>
</p></sec><sec id="irv12670-sec-0019"><label>3.7</label><title>Analytical studies</title><p>In an observational study from South Africa, hospitalized cases with influenza&#x02010;PTB co&#x02010;infection compared to cases with tuberculosis only had increased risk of death (adjusted relative risk ratio [aRRR 3.1, 95% CI 1.1&#x02010;10.1]). This association was, however, only observed in patients with symptoms &#x02265;7&#x000a0;days (aRRR 5.5, 95% CI 1.2&#x02010;25.30) and not in cases with symptoms &#x0003c;7&#x000a0;days (aRRR 0.9, 95% CI 0.1&#x02010;8.6).<xref rid="irv12670-bib-0032" ref-type="ref">32</xref> In a case series during an influenza B epidemic in a Danish tuberculosis sanatorium, 13% (7/53) of individuals co&#x02010;infected with influenza viruses compared to 2% (3/142) of individuals with tuberculosis only developed tuberculosis complications which included radiological changes or sputum conversion back to being positive (<italic>P</italic>&#x000a0;=&#x000a0;.005).<xref rid="irv12670-bib-0028" ref-type="ref">28</xref> Among children admitted with suspected tuberculosis in a study from South Africa, a higher prevalence of influenza C was detected in children with laboratory&#x02010;confirmed PTB compared with unlikely tuberculosis (18% [6/34] vs 4% [4/94], <italic>P</italic>&#x000a0;=&#x000a0;.04).<xref rid="irv12670-bib-0033" ref-type="ref">33</xref> A case&#x02010;control study from Indonesia investigating the putative association between tuberculosis and influenza virus infection reported no association between the development of clinically active PTB, either through reactivation of latent tuberculosis or directly after exposure to <italic>M&#x000a0;tuberculosis</italic>, and influenza virus infection as measured by unpaired serology in cases with newly diagnosed tuberculosis and community controls. The proportion of individuals with influenza virus antibody titres &#x02265;10 against influenza A(H3N2) and A(H1N1) viruses in patients with tuberculosis were similar to matched community controls; however, the antibody titre levels for influenza A(H3N2) virus at time of tuberculosis diagnosis were significantly higher (1.7 times higher, <italic>P</italic>&#x000a0;=&#x000a0;.002) in cases with PTB compared to controls. In addition, the difference in titres between cases with advanced PTB on chest X&#x02010;ray and their controls was significantly higher than in cases with mild to moderate tuberculosis and their controls.<xref rid="irv12670-bib-0031" ref-type="ref">31</xref> Among 23 patients with concurrent PTB and influenza infection from Thailand, none died, compared with 30 (4.7%) deaths among the individuals with only tuberculosis; however, this was not statistically significant (<italic>P</italic>&#x000a0;=&#x000a0;.62).<xref rid="irv12670-bib-0030" ref-type="ref">30</xref>
</p></sec><sec id="irv12670-sec-0020"><label>3.8</label><title>Summary of quality of human studies</title><p>Of the eight analytical studies, three were high&#x02010;quality studies as assessed by the Newcastle&#x02010;Ottawa score, of which one showed an association between influenza&#x02010;PTB co&#x02010;infection and increased mortality compared with tuberculosis only<xref rid="irv12670-bib-0032" ref-type="ref">32</xref> and two showed no association between co&#x02010;infection and severe influenza disease<xref rid="irv12670-bib-0029" ref-type="ref">29</xref> or correlation between influenza infection and tuberculosis.<xref rid="irv12670-bib-0031" ref-type="ref">31</xref> Over a third of the studies about PTB and influenza virus co&#x02010;infection were descriptive case series that included univariate analysis, and the causal relationship could not be demonstrated. Some of the studies used clinical criteria for PTB cases; however, the specifics of the criteria used were not always fully described. Among the studies that included laboratory&#x02010;confirmed PTB, screening for tuberculosis was not done systematically.</p></sec><sec id="irv12670-sec-0021"><label>3.9</label><title>Summary of findings from experimental animal models</title><p>In murine models, five studies suggested that influenza and tuberculosis co&#x02010;infection affected tuberculosis and influenza disease presentation or outcome,<xref rid="irv12670-bib-0020" ref-type="ref">20</xref> and one study showed no effect (Table <xref rid="irv12670-tbl-0003" ref-type="table">3</xref>).<xref rid="irv12670-bib-0037" ref-type="ref">37</xref> Five of the murine studies reported on the effect of influenza on tuberculosis, and one study reported on the effect of influenza on tuberculosis and the effect of tuberculosis on influenza.</p><table-wrap id="irv12670-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Summary of experimental animal studies exploring the interaction between influenza and tuberculosis</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Reference</th><th align="left" valign="top" rowspan="1" colspan="1">Objective</th><th align="left" valign="top" rowspan="1" colspan="1">Experiment</th><th align="left" valign="top" rowspan="1" colspan="1">Influenza strain/TB</th><th align="left" valign="top" rowspan="1" colspan="1">Period/ observation period</th><th align="left" valign="top" rowspan="1" colspan="1">Findings</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Volkert (1947)<xref rid="irv12670-bib-0020" ref-type="ref">20</xref>
</td><td align="left" rowspan="1" colspan="1">Does viral infection of the lungs superimposed on tubercle bacilli infection alter cause and outcome of infection due to bacterium</td><td align="left" rowspan="1" colspan="1">
<p>Model: Mice
<list list-type="simple" id="irv12670-list-0002"><list-item><p>1. Experiment group 1</p></list-item></list>
</p>
<p>Experimental group
<list list-type="bullet" id="irv12670-list-0003"><list-item><p>Simultaneous TB bacilli given intraperitoneally and influenza A virus (PR8) intra nasally</p></list-item></list>
</p>
<p>Control group 1:</p>
<p>Inoculated with TB only</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0004"><list-item><p>Number of gross tuberculosis pulmonary lesions measured at 3&#x000a0;wk</p></list-item></list>
</p>
<p>Experiment group 2:
<list list-type="bullet" id="irv12670-list-0005"><list-item><p>Inoculation with TB bacilli and influenza 3&#x000a0;wk later</p></list-item></list>
</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0006"><list-item><p>Number of gross TB pulmonary lesions measured 6&#x000a0;wk after TB infection (3&#x000a0;wk after influenza challenge)</p></list-item></list>
</p>
</td><td align="left" rowspan="1" colspan="1">Influenza A PR8/ culture of tubercle bacilli</td><td align="left" rowspan="1" colspan="1">3 and 6&#x000a0;wk</td><td align="left" rowspan="1" colspan="1">
<p>Experimental group 1
<list list-type="bullet" id="irv12670-list-0007"><list-item><p>Increased number and extent of pulmonary lesions compared to control group</p></list-item></list>
</p>
<p>Experimental group 2:
<list list-type="bullet" id="irv12670-list-0008"><list-item><p>Increased number and extent of pulmonary lesions compared to control group</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Florido (2013)<xref rid="irv12670-bib-0038" ref-type="ref">38</xref>
</td><td align="left" rowspan="1" colspan="1">Assessed impact of influenza A virus and mycobacterial respiratory co&#x02010;infection on development of CD8 T&#x02010;cell responses to each pathogen</td><td align="left" rowspan="1" colspan="1">
<p>Experiment 1</p>
<p>Experimental group:
<list list-type="bullet" id="irv12670-list-0009"><list-item><p>
<italic>Mycobacterium bovis</italic> bacille Calmette&#x02010;Guerin (BCG) and influenza A/PR8 at D1</p></list-item></list>
</p>
<p>Control groups:
<list list-type="bullet" id="irv12670-list-0010"><list-item><p>BCG only at D1</p></list-item></list>
</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0011"><list-item><p>Number of BCG and influenza&#x02010;specific CD4 and CD8 T cells, number of mycobacteria, viral titres, and number of leucocytes at D7, D14 and D21 post&#x02010;infection</p></list-item></list>
</p>
<p>Experiment 2:</p>
<p>Experimental group:
<list list-type="bullet" id="irv12670-list-0012"><list-item><p>BCG at D1, and influenza infection at 7&#x000a0;wk</p></list-item></list>
</p>
<p>Control group:
<list list-type="bullet" id="irv12670-list-0013"><list-item><p>BCG at D1, TB treatment at week 3 (for 4&#x000a0;wk) and influenza infection at 7&#x000a0;wk</p></list-item></list>
</p>
<p>Outcomes:</p>
<p>BCG&#x02010;specific CD8 T&#x02010;cell response D21 post&#x02010;influenza</p>
</td><td align="left" rowspan="1" colspan="1">Influenza A/ PR8; BCG</td><td align="left" rowspan="1" colspan="1">
<p>Experiment 1:7, 14, 21&#x000a0;d post&#x02010;infection;</p>
<p>Experiment 2</p>
<p>21&#x000a0;d post&#x02010;influenza challenge (challenge at 7&#x000a0;wk)</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Experiment 1
<list list-type="bullet" id="irv12670-list-0014"><list-item><p>Experimental (co&#x02010;infected) group&#x02014;reduced frequency and magnitude of BCG&#x02010;specific CD8 T cells in the lungs and reduced magnitude of BCG&#x02010;specific CD4 and CD8 T cell IFN&#x003b3;&#x02014;secreting responses; no difference in influenza&#x02010;specific CD8 T cells</p></list-item><list-item><p>Co&#x02010;infected group had increased number of viable BCG ova</p></list-item><list-item><p>Co&#x02010;infected group had more extensive/persistent leucocyte accumulation</p></list-item></list>
</p>
<p>Experiment 2&#x02010;
<list list-type="bullet" id="irv12670-list-0015"><list-item><p>Experimental group had reduced BCG&#x02010; specific CD8 T&#x02010;cell response</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="2" colspan="1">Redford (2014)<xref rid="irv12670-bib-0039" ref-type="ref">39</xref>
</td><td align="left" rowspan="2" colspan="1">
<p>1. Effect of prior IAV on susceptibility to tuberculosis</p>
<p>2. Effect of IAV/<italic>M&#x000a0;tuberculosis</italic> co&#x02010;infection on control of TB</p>
</td><td align="left" rowspan="2" colspan="1">
<p>Model: mice</p>
<p>1. Experimental group:
<list list-type="bullet" id="irv12670-list-0016"><list-item><p>Intranasal IAV on D1, aerosolized MTB on D28</p></list-item></list>
</p>
<p>Control group:
<list list-type="bullet" id="irv12670-list-0017"><list-item><p>Intranasal placebo (phosphate&#x02010;buffered saline [PBS]) on D1, MTB on D28</p></list-item></list>
</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0018"><list-item><p>lung inflammation, survival, number of viable bacteria in lung tissue</p></list-item></list>
</p>
<p>2. Experimental group 2:
<list list-type="bullet" id="irv12670-list-0019"><list-item><p>Aerosolized MTB D1, intranasal IAV (subtype (Cal/09) on D1 and IAV (subtype X3) on D14</p></list-item></list>
</p>
<p>Control group:
<list list-type="bullet" id="irv12670-list-0020"><list-item><p>Aerosolized MTB D1, placebo (PBS) on D1 and D14</p></list-item></list>
</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0021"><list-item><p>Number of viable MTB measured on D27</p></list-item></list>
</p>
</td><td align="left" rowspan="2" colspan="1">Influenza A Virus/ <italic>M&#x000a0;tuberculosis</italic>
</td><td align="left" rowspan="1" colspan="1">Model 1:120&#x000a0;d</td><td align="left" rowspan="1" colspan="1">
<p>Model 1
<list list-type="bullet" id="irv12670-list-0022"><list-item><p>Experimental group 1 had significant increase in inflammation, decreased survival, higher number viable MTB in lung compared to the control group</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2:27&#x000a0;d</td><td align="left" rowspan="1" colspan="1">
<p>Model 2
<list list-type="bullet" id="irv12670-list-0023"><list-item><p>Experimental group had significantly increased mycobacterial load compared to control group</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Bernard, (1962)<xref rid="irv12670-bib-0037" ref-type="ref">37</xref>
</td><td align="left" rowspan="1" colspan="1">
<p>Assessed the effect of influenza infection on TB&#x02010; infected mice.</p>
<p>Measured TB bacilli per nodule in the sacrificed mice and time from infection to death for the mice that were not sacrificed</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Model: Mice</p>
<p>Experimental group</p>
<p>Groups 1, 2, 3, 4 and 5 (10 mice in each)
<list list-type="bullet" id="irv12670-list-0024"><list-item><p>TB challenge at week 1, 2, 3, 4 and 5, respectively. Influenza challenge at week 6. 50% of mice sacrificed 15&#x000a0;d post&#x02010;influenza challenge</p></list-item></list>
</p>
<p>Group 6 (20 mice)&#x02010;
<list list-type="bullet" id="irv12670-list-0025"><list-item><p>influenza only challenge at week 6 for all; Not sacrificed</p></list-item></list>
</p>
<p>Control groups</p>
<p>Groups 1, 2, 3, 4 and 5 (10 mice in each)
<list list-type="bullet" id="irv12670-list-0026"><list-item><p>TB challenge at week 1, 2, 3, 4 and 5, respectively. No influenza challenge</p></list-item></list>
</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0027"><list-item><p>Number of TB bacilli per nodule in the sacrificed mice</p></list-item><list-item><p>Time from TB infection to death for the mice that were not sacrificed</p></list-item></list>
</p>
</td><td align="left" rowspan="1" colspan="1">H 37 RV strain of TB</td><td align="left" rowspan="1" colspan="1">173&#x000a0;d, 50% of mice in experimental groups 1&#x02010;5 sacrificed 15&#x000a0;d post&#x02010;influenza challenge</td><td align="left" rowspan="1" colspan="1">
<list list-type="bullet" id="irv12670-list-0028"><list-item><p>Experimental groups had 50%&#x02010;75% lower survival time and had increased number of bacilli per nodules. Effect of influenza infection on TB severity increased with increasing duration of TB infection before influenza challenge</p></list-item><list-item><p>Among non&#x02010;sacrificed mice, death in 25/25 (100%) co&#x02010;infected vs 1/20 (5%) infected with influenza only</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Massanari (<xref rid="irv12670-bib-0040" ref-type="ref">40</xref>)</td><td align="left" rowspan="1" colspan="1">Examined tuberculin hypersensitivity during superimposed acute influenza infection</td><td align="left" rowspan="1" colspan="1">
<p>Model: Mice</p>
<p>Experimental groups 1:
<list list-type="bullet" id="irv12670-list-0029"><list-item><p>Influenza virus, intranasal (i.n.) 4&#x02010;6&#x000a0;wk after <italic>M&#x000a0;tuberculosis</italic> infection</p></list-item></list>
</p>
<p>Experimental group 2
<list list-type="bullet" id="irv12670-list-0030"><list-item><p>Formalin&#x02010;inactivated influenza virus (i.n.) or intravenous (i.v.) live influenza virus 4&#x02010;6&#x000a0;wk after <italic>M&#x000a0;tuberculosis</italic> infection</p></list-item></list>
</p>
<p>Control group</p>
<p>Inoculated with PBS, 4&#x02010;6&#x000a0;wk after <italic>M&#x000a0;tuberculosis</italic> infection</p>
<p>Outcomes:
<list list-type="bullet" id="irv12670-list-0031"><list-item><p>Tuberculin hypersensitivity (measured as footpad swelling) 6&#x000a0;d after influenza, PBS challenge</p></list-item><list-item><p>Number of circulating lymphocytes post&#x02010;influenza challenge</p></list-item></list>
</p>
</td><td align="left" rowspan="1" colspan="1">
<italic>M&#x000a0;tuberculosis</italic> and influenza A/PR8</td><td align="left" rowspan="1" colspan="1">4&#x02010;6&#x000a0;wk after TB infection</td><td align="left" rowspan="1" colspan="1">
<p>Experimental group 1
<list list-type="bullet" id="irv12670-list-0032"><list-item><p>Suppressed tuberculin hypersensitivity from D3 to D16 post&#x02013;intranasal influenza infection. Suppression of immune response preceded presentation of clinical signs of influenza</p></list-item><list-item><p>Reduction in lymphocytes on D 2, 5, 7 post&#x02010;influenza challenge compared to values before influenza infection</p></list-item></list>
</p>
<p>Experimental group 2
<list list-type="bullet" id="irv12670-list-0033"><list-item><p>No immunosuppression in experimental group 2</p></list-item></list>
</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Co (2006)<xref rid="irv12670-bib-0041" ref-type="ref">41</xref>
</td><td align="left" rowspan="1" colspan="1">
<p>Tested how BCG&#x02010;specific and influenza&#x02010;specific CD4 T</p>
<p>cells distribute between the two inflammatory sites (lungs and liver), how these two T cells would interfere with each other and how these interactions affect granuloma formation, dissemination,</p>
<p>and control of BCG</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Model: Mice</p>
<p>Experimental groups:
<list list-type="bullet" id="irv12670-list-0034"><list-item><p>Mice chronically infected with BCG and intranasal hen egg lysozyme (HEL&#x02010;flu) influenza challenge 5&#x000a0;wk post&#x02010;BCG</p></list-item><list-item><p>Mice chronically infected with BCG and wild type (wt) influenza challenge 5&#x000a0;wk post&#x02010;BCG</p></list-item></list>
</p>
<p>Control group:
<list list-type="bullet" id="irv12670-list-0035"><list-item><p>Mice infected with BCG alone</p></list-item></list>
</p>
<p>Outcome:</p>
<p>Number of AFB per lesion, number of granuloma lesions and dissemination of mycobacteria from granuloma</p>
</td><td align="left" rowspan="1" colspan="1">HEL&#x02010;flu or wt. influenza virus/ BCG</td><td align="left" rowspan="1" colspan="1">5&#x000a0;wk 6&#x000a0;d</td><td align="left" rowspan="1" colspan="1">
<p>Experimental groups
<list list-type="bullet" id="irv12670-list-0036"><list-item><p>Increase in numbers of granulomas/field (granuloma burden) in experimental groups compared to controls</p></list-item><list-item><p>Slight increase in number of AFB per lesion compared to the control group</p></list-item><list-item><p>No dissemination of mycobacteria from granuloma</p></list-item></list>
</p>
<p>Interpretation: Co&#x02010;infection with influenza had little effect on mycobacterial load mycobacteria did not disseminate in either group</p>
</td></tr></tbody></table><table-wrap-foot id="irv12670-ntgp-0003"><fn id="irv12670-note-0007"><p>Abbreviations: BCG, Calmette&#x02010;Guerin; HEL, hen egg lysozyme; IAV, influenza A virus; IFN, interferon; <italic>M&#x000a0;tuberculosis</italic>, <italic>Mycobacterium tuberculosis</italic>; TB, tuberculosis.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="irv12670-sec-0022"><label>3.10</label><title>Effect of influenza on tuberculosis</title><p>Volkert et al<xref rid="irv12670-bib-0020" ref-type="ref">20</xref> showed that the course of experimental infection with tubercle bacillus in mice was worsened by simultaneous influenza infection (influenza A virus and tubercle bacilli challenge at week 0) and influenza infection superimposed on tuberculosis infection (influenza challenge 3&#x000a0;weeks after TB challenge). Co&#x02010;infection resulted in more extensive and rapid development of PTB lesions in mice than infection with tubercle bacillus only. Florido et al<xref rid="irv12670-bib-0038" ref-type="ref">38</xref> reported that pulmonary bacille Calmette&#x02010;Guerin (BCG)&#x02010;specific CD8 T&#x02010;cell responses were impaired in co&#x02010;infected mice. Concurrent infection of mice with influenza virus and BCG (challenge on day 0) and sequential infection of mice with TB and influenza virus (TB infection on day 0 and influenza virus 7&#x000a0;weeks later) compared to infection with BCG only resulted in reduction in BCG&#x02010;specific CD4 and CD8 T&#x02010;cell responses, increased pulmonary disease and a delay in mycobacterium clearance from the lungs of infected mice. For sequential infection with influenza, the reduction in BCG&#x02010;specific CD8 T&#x02010;cell response was only evident in mice with untreated TB compared with mice that had cleared TB. Concurrent infection with influenza virus and tuberculosis reduced generation of protective T&#x02010;cell responses against intracellular mycobacteria but did not affect control of pulmonary influenza viral loads (no difference between co&#x02010;infected mice compared with the influenza only group).<xref rid="irv12670-bib-0038" ref-type="ref">38</xref>
</p><p>Redford et al<xref rid="irv12670-bib-0039" ref-type="ref">39</xref> demonstrated that influenza A virus infection of mice 28&#x000a0;days before or during (on day 1 or day 14) <italic>M&#x000a0;tuberculosis</italic> infection enhanced susceptibility to tuberculosis and impaired mycobacterium control and decreased host survival. Bernard et al<xref rid="irv12670-bib-0037" ref-type="ref">37</xref> showed that in <italic>M&#x000a0;tuberculosis</italic>&#x02010;infected mice, influenza virus challenge 1&#x02010;5&#x000a0;weeks after <italic>M&#x000a0;tuberculosis</italic> infection, compared with <italic>M&#x000a0;tuberculosis</italic>&#x02010;only infected mice, resulted in 50%&#x02010;75% shorter survival time and a higher case&#x02010;fatality rate. In addition, the effect of influenza virus on tuberculosis severity, measured by amount of tissue damage, increased with increasing time of tuberculosis infection prior to the influenza virus challenge. Five per cent of the mice infected with influenza alone died compared to 100% of the mice infected with influenza and tuberculosis. This was corroborated in a study by Bernard et al<xref rid="irv12670-bib-0037" ref-type="ref">37</xref> in which 5% of the mice infected with influenza alone died compared to 100% of the mice infected with influenza and tuberculosis (Table <xref rid="irv12670-tbl-0003" ref-type="table">3</xref>). </p><p>Massanari (<xref rid="irv12670-bib-0040" ref-type="ref">40</xref>) reported that tuberculin hypersensitivity in mice was temporarily suppressed following an intranasal influenza virus challenge; however, a normal response resumed after resolution of influenza virus infection. Tuberculin hypersensitivity, tested 4&#x02010;6&#x000a0;weeks after tuberculosis infection, was temporarily suppressed from day 3 to day 16 post an intranasal influenza virus challenge.<xref rid="irv12670-bib-0040" ref-type="ref">40</xref> In contrast, Co et al<xref rid="irv12670-bib-0041" ref-type="ref">41</xref> showed that influenza viruses had little effect on mycobacterial load and did not affect dissemination of tuberculosis in a mouse model. They showed that T cells responding to an acute influenza virus infection can modulate host responses to an ongoing BCG infection. Though not statistically significant, acute infection with influenza in mice with chronic <italic>Mycobacterium bovis</italic> BCG infection moderately increased the acid&#x02010;fast bacilli load in the liver.<xref rid="irv12670-bib-0041" ref-type="ref">41</xref>
</p></sec></sec><sec sec-type="discussion" id="irv12670-sec-0023"><label>4</label><title>DISCUSSION</title><p>Our systematic review suggests that analytical studies exploring the interaction between laboratory&#x02010;confirmed influenza virus infection and clinically diagnosed or laboratory&#x02010;confirmed PTB are severely limited. Experimental animal studies suggest an association, specifically that influenza&#x02010;tuberculosis co&#x02010;infection in mice results in more severe disease than influenza only or tuberculosis only disease. Observational studies among humans showed mixed results. Fifty per cent (4/8) of the analytical studies, one of which was of high quality, showed an association between co&#x02010;infection and severe influenza&#x02010; or tuberculosis&#x02010;associated disease or increased prevalence of influenza co&#x02010;infection in individuals hospitalized for tuberculosis.<xref rid="irv12670-bib-0027" ref-type="ref">27</xref>, <xref rid="irv12670-bib-0028" ref-type="ref">28</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref>, <xref rid="irv12670-bib-0033" ref-type="ref">33</xref> The other half (4/8) of the analytical studies, two of which were of high quality, showed no association between co&#x02010;infection and progression of tuberculosis or influenza disease or severe outcomes, that is they did not show that influenza affected PTB presentation and outcomes, or that PTB affected influenza presentation and outcomes. Three of the descriptive studies, although not assessed for statistical significance, reported either a high prevalence of co&#x02010;infection in cases with severe influenza disease<xref rid="irv12670-bib-0034" ref-type="ref">34</xref>, <xref rid="irv12670-bib-0035" ref-type="ref">35</xref> or increased severe disease or progression of disease in co&#x02010;infected individuals.<xref rid="irv12670-bib-0026" ref-type="ref">26</xref>
</p><p>Of the five studies reporting on pandemic influenza only, two descriptive studies from HBCs reported a high prevalence of tuberculosis in cases with severe influenza&#x02010;associated disease.<xref rid="irv12670-bib-0034" ref-type="ref">34</xref>, <xref rid="irv12670-bib-0035" ref-type="ref">35</xref> These studies presented limited univariate analyses. Pandemic influenza may behave differently to seasonal influenza because of lack of pre&#x02010;existing immunity, and the likely interaction between influenza and tuberculosis might be immunologically mediated. High levels of cytokines produced as part of the inflammatory response to infection with a pandemic virus have been reported to result in severe influenza&#x02010;associated lung damage.<xref rid="irv12670-bib-0042" ref-type="ref">42</xref> Some studies have demonstrated a higher mortality due to 2009 pandemic influenza as compared to seasonal influenza.<xref rid="irv12670-bib-0043" ref-type="ref">43</xref>, <xref rid="irv12670-bib-0044" ref-type="ref">44</xref>, <xref rid="irv12670-bib-0045" ref-type="ref">45</xref> High&#x02010;quality epidemiological studies are required to assess whether the severe disease and outcomes associated with influenza&#x02010;PTB co&#x02010;infection are driven by pandemic phenomena as this may have implications for recommendations and prevention strategies. However, even if the association between influenza and PTB is less marked during seasonal influenza epidemics, targeting individuals with active PTB for influenza vaccination and antiviral treatment in HBCs could still potentially prevent significant morbidity and mortality and might also prevent further spread of tuberculosis during the intensive phase if influenza increases coughing. In this review, all the analytical studies were conducted in high burden countries. It is important to understand the background prevalence of tuberculosis where studies are conducted for better interpretation of the results. In countries with low tuberculosis burden, it is possible for studies not to identify increased prevalence of co&#x02010;infection or detect an association between co&#x02010;infection and severe outcomes, purely because of low numbers due to low tuberculosis prevalence in the community. In some of the analytical studies included in our review, lack of association may be due to the inclusion criteria, for example only including lower respiratory tract infection (LRTI) cases with acute presentation and not systematically testing for PTB in patients with severe respiratory illness. Depending on the magnitude of tuberculosis burden, results may have different implications for prioritization in different settings.</p><p>Since the 1950s, authors have recommended influenza vaccination among patients with tuberculosis during influenza epidemics.<xref rid="irv12670-bib-0028" ref-type="ref">28</xref> Influenza vaccination is the most effective way to prevent influenza&#x02010;associated disease. Influenza vaccine has been shown to generate antibody response in patients with tuberculosis that is similar to those without tuberculosis, although these studies were conducted in the 1950s and 1960s and did not include HIV&#x02010;infected individuals.<xref rid="irv12670-bib-0036" ref-type="ref">36</xref> Antiviral treatment for influenza improves outcomes for patients with severe influenza&#x02010;associated disease.<xref rid="irv12670-bib-0046" ref-type="ref">46</xref> However, both vaccines and antiviral treatment have cost implications and are not easily accessible in low&#x02010; to middle&#x02010;income countries where the burden of tuberculosis and influenza are high.<xref rid="irv12670-bib-0047" ref-type="ref">47</xref> Identifying PTB patients as a risk group for severe influenza&#x02010;associated disease may assist policymakers in making decisions about prioritizing this group of patients for influenza vaccination and treatment with influenza antiviral treatment. More high&#x02010;quality epidemiological data from high tuberculosis burden settings are needed to address this question. In addition, more studies are needed to determine whether seasonal or pandemic vaccines or influenza antivirals should be prioritized for PTB patients and whether patients hospitalized with influenza&#x02010;associated illness should be investigated for PTB.</p><p>Although some descriptive and analytical studies inferred worsening of PTB in co&#x02010;infected individuals,<xref rid="irv12670-bib-0026" ref-type="ref">26</xref>, <xref rid="irv12670-bib-0036" ref-type="ref">36</xref>, <xref rid="irv12670-bib-0048" ref-type="ref">48</xref> besides the methodological limitations of the studies, changes reported could have simply reflected a superimposed viral or bacterial infection in cases with the underlying PTB rather than worsening of tuberculosis. In addition, there was no comparison of radiological findings in patients with and without co&#x02010;infection to assess whether changes in the lungs were a factor in the presentation or outcomes of influenza&#x02010;associated disease. The one study which showed an increase in pulmonary lesions did not present results on whether the radiological changes correlated with deterioration in clinical presentation.</p><p>One of the studies suggested that compared to individuals infected only with tuberculosis, individuals with influenza&#x02010;PTB co&#x02010;infection had increased risk of death, and this association was not observed in patients with a more acute presentation. If cases with more chronic PTB are more at risk of severe influenza disease, this might explain the lack of association in some of the studies which only included LRTI patients with an acute presentation.<xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref> If the association with severe disease and poor outcomes is more prevalent in patients with a more chronic presentation, this may further assist in making decisions about which tuberculosis cases to prioritize for interventions, especially in countries where the tuberculosis burden is high and resources are limited.</p><p>The mechanism by which influenza&#x02010;PTB co&#x02010;infection leads to severe influenza&#x02010;associated disease may be secondary to the underlying lung damage caused by PTB. It is possible that those who had severe outcomes from co&#x02010;infection already had the underlying lung damage from PTB leading to reduced lung capacity to deal with a viral infection such as influenza. Seki et al<xref rid="irv12670-bib-0049" ref-type="ref">49</xref> suggested that the underlying chronic lung diseases such as tuberculosis may be an important factor in the increase in frequency of secondary bacterial pneumonia in persons with influenza, which in turn can lead to increased frequency of complications.</p><p>Some of the studies reported on tuberculosis in patients from sanatorium.<xref rid="irv12670-bib-0026" ref-type="ref">26</xref>, <xref rid="irv12670-bib-0028" ref-type="ref">28</xref>, <xref rid="irv12670-bib-0036" ref-type="ref">36</xref> It is possible that the high prevalence of influenza reported in these studies is due to increased risk of influenza transmission resulting in high transmission rates in these closed settings. In addition, the influenza transmission may not reflect community&#x02010;acquired influenza and results from these studies cannot be generalizable to other settings. Due to a possibility of increased risk of high concentration of persons with co&#x02010;morbidities resulting in poor outcomes, closed settings should be prioritized for influenza vaccination.</p><p>There were a number of limitations to this systematic review. Broad search terms were used to increase sensitivity to identify relevant articles, although this may have somewhat reduced search specificity. Over a third of the observational studies were descriptive, and due to the nature of these studies, an association could not be evaluated. The type of tuberculosis included differed among the studies, with some studies reporting newly diagnosed tuberculosis, some reporting on cases in a tuberculosis sanatorium for a number of months and some included cases who had completed tuberculosis treatment, thus making data less comparable. There were differences in the population tuberculosis incidences where studies were conducted which could affect the power to detect an association. However, the majority of studies were from tuberculosis high burden countries or were conducted during the period when tuberculosis burden was high. We included animal studies although these may not be generalizable to humans.</p><p>Many studies did not adequately assess the underlying conditions such as HIV and malnutrition. HIV infection is a risk factor for severe influenza disease as well as for PTB, and it is an important contributor to the overall burden of severe influenza in high HIV&#x02010;prevalence settings.<xref rid="irv12670-bib-0050" ref-type="ref">50</xref>, <xref rid="irv12670-bib-0051" ref-type="ref">51</xref> However, only a few papers reported data on HIV infection.<xref rid="irv12670-bib-0027" ref-type="ref">27</xref>, <xref rid="irv12670-bib-0029" ref-type="ref">29</xref>, <xref rid="irv12670-bib-0030" ref-type="ref">30</xref>, <xref rid="irv12670-bib-0032" ref-type="ref">32</xref> In one study, patients with co&#x02010;infection of HIV and PTB were at high risk of being hospitalized with influenza; however, the number of co&#x02010;infected individuals was low and the association was not statistically significant.<xref rid="irv12670-bib-0029" ref-type="ref">29</xref> If the association with severe disease is higher in patients with the underlying HIV infection, it may be difficult to differentiate the role played by the individual infection. Other conditions such as malnutrition, which like tuberculosis are prevalent in HBC, were not evaluated in included articles and may be confounders in the association between influenza and PTB. The numbers of participants in most studies were small, and this could have limited the ability to detect significant associations. Other important areas that were not addressed by the studies reviewed include whether influenza infection caused reactivation of latent tuberculosis or whether the acute viral infection precipitated a visit to the doctor in patients who already had tuberculosis disease. Studies in Chinese were not included in the review, and therefore, our review may not reflect the full body of literature on this topic.</p></sec><sec sec-type="conclusions" id="irv12670-sec-0024"><label>5</label><title>CONCLUSION</title><p>Although the majority of experimental animal studies suggested increased severity of disease with co&#x02010;infection of influenza and PTB, only half of the analytical studies on influenza and PTB in humans found the same. Descriptive studies, although they could not evaluate an association, reported an increased prevalence of co&#x02010;infection among cases with severe influenza or PTB disease. Data are limited from large epidemiological studies, studies with laboratory&#x02010;confirmed influenza and PTB, studies from high tuberculosis burden settings and studies that include data on HIV. In order to study the association between influenza and PTB and make inferences about causal associations, more epidemiological studies with systematic testing for influenza and tuberculosis are needed.</p></sec><sec sec-type="COI-statement" id="irv12670-sec-0025"><title>CONFLICT OF INTEREST</title><p>No authors have any competing interests.</p></sec><sec id="irv12670-sec-0027"><title>AUTHOR CONTRIBUTIONS</title><p>SW and ALC conceived and designed the experiments; SW, ST, MM, AN, CC, JM and ALC performed the experiments and analysed the data; SW, ST, MM, AN, CC, SAM, JM and ALC wrote and reviewed the paper.</p></sec><sec id="irv12670-sec-0026"><title>DISCLAIMER</title><p>The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="irv12670-sup-0001"><caption><p>&#x000a0;</p></caption><media xlink:href="IRV-14-77-s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="irv12670-sup-0002"><caption><p>&#x000a0;</p></caption><media xlink:href="IRV-14-77-s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="irv12670-sup-0003"><caption><p>&#x000a0;</p></caption><media xlink:href="IRV-14-77-s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="irv12670-sec-0028"><title>ACKNOWLEDGEMENTS</title><p>We thank Professor Anne von Gottberg for translating the papers published in German and Tatiana Baranovich for translating the abstracts published in Russian.</p></ack><ref-list content-type="cited-references" id="irv12670-bibl-0001"><title>REFERENCES</title><ref id="irv12670-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="irv12670-cit-0001">
<string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Simonsen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>J&#x02010;W</given-names>
</string-name>, et al. <article-title>Elevated influenza&#x02010;related excess mortality in South African elderly individuals, 1998&#x02013;2005</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2010</year>;<volume>51</volume>(<issue>12</issue>):<fpage>1362</fpage>&#x02010;<lpage>1369</lpage>.<pub-id pub-id-type="pmid">21070141</pub-id></mixed-citation></ref><ref id="irv12670-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="irv12670-cit-0002">
<string-name>
<surname>Nair</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Katz</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta&#x02010;analysis</article-title>. <source xml:lang="en">Lancet</source>. <year>2011</year>;<volume>378</volume>(<issue>9807</issue>):<fpage>1917</fpage>&#x02010;<lpage>1930</lpage>.<pub-id pub-id-type="pmid">22078723</pub-id></mixed-citation></ref><ref id="irv12670-bib-0003"><label>3</label><mixed-citation publication-type="book" id="irv12670-cit-0003">
<collab collab-type="authors">World Health Organization</collab>
. <source xml:lang="en">Global tuberculosis report 2014</source>; <year>2014</year>.</mixed-citation></ref><ref id="irv12670-bib-0004"><label>4</label><mixed-citation publication-type="book" id="irv12670-cit-0004">
<collab collab-type="authors">World Health Organization</collab>
. <source xml:lang="en">Seasonal influenza</source>, vol. 211; <year>2014</year>.</mixed-citation></ref><ref id="irv12670-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="irv12670-cit-0005">
<string-name>
<surname>Iuliano</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Roguski</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>HH</given-names>
</string-name>, et al. <article-title>Estimates of global seasonal influenza&#x02010;associated respiratory mortality: a modelling study</article-title>. <source xml:lang="en">Lancet</source>. <year>2018</year>;<volume>391</volume>(<issue>10127</issue>):<fpage>1285</fpage>&#x02010;<lpage>1300</lpage>.<pub-id pub-id-type="pmid">29248255</pub-id></mixed-citation></ref><ref id="irv12670-bib-0006"><label>6</label><mixed-citation publication-type="book" id="irv12670-cit-0006">
<collab collab-type="authors">World Health Organization</collab>
. <source xml:lang="en">Global tuberculosis report 2016</source>. <publisher-name>WHO</publisher-name>;<year>2016</year>;<fpage>1</fpage>&#x02010;<lpage>201</lpage>.</mixed-citation></ref><ref id="irv12670-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="irv12670-cit-0007">
<string-name>
<surname>Small</surname>
<given-names>C&#x02010;L</given-names>
</string-name>, <string-name>
<surname>Shaler</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>McCormick</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung</article-title>. <source xml:lang="en">J Immunol</source>. <year>2010</year>;<volume>184</volume>(<issue>4</issue>):<fpage>2048</fpage>&#x02010;<lpage>2056</lpage>.<pub-id pub-id-type="pmid">20083661</pub-id></mixed-citation></ref><ref id="irv12670-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="irv12670-cit-0008">
<string-name>
<surname>Jamieson</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Annicelli</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Medzhitov</surname>
<given-names>R</given-names>
</string-name>. <article-title>Influenza virus&#x02010;induced glucocorticoids compromise innate host defense against a secondary bacterial infection</article-title>. <source xml:lang="en">Cell Host Microbe</source>. <year>2010</year>;<volume>7</volume>(<issue>2</issue>):<fpage>103</fpage>&#x02010;<lpage>114</lpage>.<pub-id pub-id-type="pmid">20159617</pub-id></mixed-citation></ref><ref id="irv12670-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="irv12670-cit-0009">
<string-name>
<surname>Shahangian</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chow</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source xml:lang="en">J Clin Invest</source>. <year>2009</year>;<volume>119</volume>(<issue>7</issue>):<fpage>1910</fpage>&#x02010;<lpage>1920</lpage>.<pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="irv12670-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="irv12670-cit-0010">
<string-name>
<surname>Ballinger</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Standiford</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>Postinfluenza bacterial pneumonia: host defenses gone awry</article-title>. <source xml:lang="en">J Interferon Cytokine Res</source>. <year>2010</year>;<volume>30</volume>(<issue>9</issue>):<fpage>643</fpage>&#x02010;<lpage>652</lpage>.<pub-id pub-id-type="pmid">20726789</pub-id></mixed-citation></ref><ref id="irv12670-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="irv12670-cit-0011">
<string-name>
<surname>Gardner</surname>
<given-names>ID</given-names>
</string-name>. <article-title>Suppression of antibacterial immunity by infection with influenza virus</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>1981</year>;<volume>144</volume>(<issue>3</issue>):<fpage>225</fpage>&#x02010;<lpage>231</lpage>.<pub-id pub-id-type="pmid">6974206</pub-id></mixed-citation></ref><ref id="irv12670-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="irv12670-cit-0012">
<string-name>
<surname>Schliehe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Flynn</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Vilagos</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>The methyltransferase Setdb2 mediates virus&#x02010;induced susceptibility to bacterial superinfection</article-title>. <source xml:lang="en">Nat Immunol</source>. <year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>67</fpage>&#x02010;<lpage>74</lpage>.<pub-id pub-id-type="pmid">25419628</pub-id></mixed-citation></ref><ref id="irv12670-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="irv12670-cit-0013">
<string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Rehg</surname>
<given-names>JE</given-names>
</string-name>. <article-title>Lethal synergism between influenza virus and <italic>Streptococcus pneumoniae</italic>: characterization of a mouse model and the role of platelet&#x02010;activating factor receptor</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2002</year>;<volume>186</volume>(<issue>3</issue>):<fpage>341</fpage>&#x02010;<lpage>350</lpage>.<pub-id pub-id-type="pmid">12134230</pub-id></mixed-citation></ref><ref id="irv12670-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="irv12670-cit-0014">
<string-name>
<surname>Noymer</surname>
<given-names>A</given-names>
</string-name>. <article-title>The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: an age, period, cohort analysis</article-title>. <source xml:lang="en">Vaccine</source>. <year>2011</year>;<volume>29</volume>(<issue>Suppl 2</issue>):<fpage>B38</fpage>&#x02010;<lpage>41</lpage>.<pub-id pub-id-type="pmid">21757102</pub-id></mixed-citation></ref><ref id="irv12670-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="irv12670-cit-0015">
<string-name>
<surname>Oei</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Nishiura</surname>
<given-names>H</given-names>
</string-name>. <article-title>The relationship between tuberculosis and influenza death during the influenza (H1N1) pandemic from 1918&#x02013;19</article-title>. <source xml:lang="en">Comput Math Methods Med</source>. <year>2012</year>;<volume>2012</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="irv12670-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="irv12670-cit-0016">
<string-name>
<surname>Housworth</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Langmuir</surname>
<given-names>AD</given-names>
</string-name>. <article-title>Excess mortality from epidemic influenza, 1957&#x02013;1966</article-title>. <source xml:lang="en">Am J Epidemiol</source>. <year>1974</year>;<volume>100</volume>(<issue>1</issue>):<fpage>40</fpage>&#x02010;<lpage>48</lpage>.<pub-id pub-id-type="pmid">4858301</pub-id></mixed-citation></ref><ref id="irv12670-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="irv12670-cit-0017">
<string-name>
<surname>Noymer</surname>
<given-names>A</given-names>
</string-name>. <article-title>Testing the influenza&#x02013;tuberculosis selective mortality hypothesis with Union Army data</article-title>. <source xml:lang="en">Soc Sci Med</source>. <year>2009</year>;<volume>68</volume>(<issue>9</issue>):<fpage>1599</fpage>&#x02010;<lpage>1608</lpage>.<pub-id pub-id-type="pmid">19304361</pub-id></mixed-citation></ref><ref id="irv12670-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="irv12670-cit-0018">
<string-name>
<surname>Z&#x000fc;rcher</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zwahlen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ballif</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rieder</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Egger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fenner</surname>
<given-names>L</given-names>
</string-name>. <article-title>Influenza pandemics and tuberculosis mortality in 1889 and 1918: analysis of historical data from Switzerland</article-title>. <source xml:lang="en">PLoS ONE</source>. <year>2016</year>;<volume>11</volume>(<issue>10</issue>):<fpage>e0162575</fpage>.<pub-id pub-id-type="pmid">27706149</pub-id></mixed-citation></ref><ref id="irv12670-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="irv12670-cit-0019">
<string-name>
<surname>Walaza</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nanoo</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Excess mortality associated with influenza among tuberculosis deaths in South Africa, 1999&#x02013;2009</article-title>. <source xml:lang="en">PLoS ONE</source>. <year>2015</year>;<volume>10</volume>(<issue>6</issue>):<fpage>e0129173</fpage>.<pub-id pub-id-type="pmid">26076197</pub-id></mixed-citation></ref><ref id="irv12670-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="irv12670-cit-0020">
<string-name>
<surname>Volkert</surname>
<given-names>M</given-names>
</string-name>. <article-title>The enhancing effect of concurrent infection with pneumotropic viruses on pulmonary tuberculosis in mice</article-title>. <source xml:lang="en">J Exp Med</source>. <year>1947</year>;<volume>86</volume>(<issue>3</issue>):<fpage>203</fpage>&#x02010;<lpage>214</lpage>.<pub-id pub-id-type="pmid">19871671</pub-id></mixed-citation></ref><ref id="irv12670-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="irv12670-cit-0021">
<collab collab-type="authors">World Health Organization</collab>
. <article-title>Vaccines against influenza WHO position paper &#x02013; November 2012</article-title>. <source xml:lang="en">Wkly Epidemiol Rec</source>. <year>2012</year>;<volume>87</volume>:<fpage>461</fpage>&#x02010;<lpage>476</lpage>.<pub-id pub-id-type="pmid">23210147</pub-id></mixed-citation></ref><ref id="irv12670-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="irv12670-cit-0022">
<string-name>
<surname>Moher</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Liberati</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tetzlaff</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Altman</surname>
<given-names>DG</given-names>
</string-name>. <article-title>Preferred reporting items for systematic reviews and meta&#x02010;analyses: the PRISMA statement</article-title>. <source xml:lang="en">BMJ</source>. <year>2009</year>;<volume>339</volume>:<fpage>b2535</fpage>.<pub-id pub-id-type="pmid">19622551</pub-id></mixed-citation></ref><ref id="irv12670-bib-0023"><label>23</label><mixed-citation publication-type="book" id="irv12670-cit-0023">
<string-name>
<surname>Wells</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Wells</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Shea</surname>
<given-names>B</given-names>
</string-name>, et al. <source xml:lang="en">The Newcastle&#x02010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x02010;Analyses</source>.</mixed-citation></ref><ref id="irv12670-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="irv12670-cit-0024">
<string-name>
<surname>Koegelenberg</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Irusen</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>High mortality from respiratory failure secondary to swine&#x02010;origin influenza A (H1N1) in South Africa</article-title>. <source xml:lang="en">QJM</source>. <year>2010</year>;<volume>103</volume>(<issue>5</issue>):<fpage>319</fpage>&#x02010;<lpage>325</lpage>.<pub-id pub-id-type="pmid">20219780</pub-id></mixed-citation></ref><ref id="irv12670-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="irv12670-cit-0025">
<string-name>
<surname>Noh</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>WS</given-names>
</string-name>, et al. <article-title>Concurrent tuberculosis and influenza, South Korea</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2013</year>;<volume>19</volume>(<issue>1</issue>):<fpage>165</fpage>&#x02010;<lpage>167</lpage>.<pub-id pub-id-type="pmid">23260033</pub-id></mixed-citation></ref><ref id="irv12670-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="irv12670-cit-0026">
<string-name>
<surname>Dijkman</surname>
<given-names>JH</given-names>
</string-name>. <article-title>The influence of viral infections of the respiratory passages on the course of primary pulmonary and hilar tuberculosis in children</article-title>. Selected Papers of the Royal Netherlands Tuberculosis Association. <year>1967</year>;<volume>10</volume>:<fpage>5</fpage>&#x02010;<lpage>20</lpage>.</mixed-citation></ref><ref id="irv12670-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="irv12670-cit-0027">
<string-name>
<surname>Abadom</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Madhi</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Risk factors associated with hospitalisation for influenza&#x02010;associated severe acute respiratory illness in South Africa: a case&#x02010;population study</article-title>. <source xml:lang="en">Vaccine</source>. <year>2016</year>;<volume>34</volume>(<issue>46</issue>):<fpage>5649</fpage>&#x02010;<lpage>5655</lpage>.<pub-id pub-id-type="pmid">27720448</pub-id></mixed-citation></ref><ref id="irv12670-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="irv12670-cit-0028">
<string-name>
<surname>Espersen</surname>
<given-names>E</given-names>
</string-name>. <article-title>Epidemic of influenza B among Green&#x02010;landic patients in a Danish tuberculosis sanatorium. Influenza and pulmonary tuberculosis</article-title>. <source xml:lang="en">Acta Tuberc Scand</source>. <year>1954</year>;<volume>29</volume>(<issue>2</issue>):<fpage>125</fpage>&#x02010;<lpage>139</lpage>.<pub-id pub-id-type="pmid">13188754</pub-id></mixed-citation></ref><ref id="irv12670-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="irv12670-cit-0029">
<string-name>
<surname>Ope</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Katz</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Aura</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Risk factors for hospitalized seasonal influenza in rural Western Kenya</article-title>. <source xml:lang="en">PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e20111</fpage>.<pub-id pub-id-type="pmid">21637856</pub-id></mixed-citation></ref><ref id="irv12670-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="irv12670-cit-0030">
<string-name>
<surname>Roth</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Whitehead</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Thamthitiwat</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Concurrent influenza virus infection and tuberculosis in patients hospitalized with respiratory illness in Thailand</article-title>. <source xml:lang="en">Influenza Other Respir Viruses</source>. <year>2013</year>;<volume>7</volume>(<issue>3</issue>):<fpage>244</fpage>&#x02010;<lpage>248</lpage>.<pub-id pub-id-type="pmid">22817684</pub-id></mixed-citation></ref><ref id="irv12670-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="irv12670-cit-0031">
<string-name>
<surname>de Paus</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>van Crevel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van Beek</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>The influence of influenza virus infections on the development of tuberculosis</article-title>. <source xml:lang="en">Tuberculosis</source>. <year>2013</year>;<volume>93</volume>(<issue>3</issue>):<fpage>338</fpage>&#x02010;<lpage>342</lpage>.<pub-id pub-id-type="pmid">23474302</pub-id></mixed-citation></ref><ref id="irv12670-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="irv12670-cit-0032">
<string-name>
<surname>Walaza</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dawood</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010&#x02013;2011</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2015</year>;<volume>15</volume>(<issue>1</issue>):<fpage>26</fpage>.<pub-id pub-id-type="pmid">25623944</pub-id></mixed-citation></ref><ref id="irv12670-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="irv12670-cit-0033">
<string-name>
<surname>Dube</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Kaba</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Robberts</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Respiratory microbes present in the nasopharynx of children hospitalised with suspected pulmonary tuberculosis in Cape Town, South Africa</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2016</year>;<volume>16</volume>(<issue>1</issue>):<fpage>597</fpage>.<pub-id pub-id-type="pmid">27776489</pub-id></mixed-citation></ref><ref id="irv12670-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="irv12670-cit-0034">
<string-name>
<surname>Archer</surname>
<given-names>BN</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Naidoo</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases</article-title>. <source xml:lang="en">Euro Surveill</source>. <year>2009</year>;<volume>14</volume>(<issue>42</issue>):<fpage>11</fpage>-<lpage>15</lpage>.</mixed-citation></ref><ref id="irv12670-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="irv12670-cit-0035">
<string-name>
<surname>Puvanalingam</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rajendiran</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sivasubramanian</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ragunanthanan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Suresh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gopalakrishnan</surname>
<given-names>S</given-names>
</string-name>. <article-title>Case series study of the clinical profile of H1N1 swine flu influenza</article-title>. <source xml:lang="en">J Assoc Physicians India</source>. <year>2011</year>;<volume>59</volume>: <fpage>14</fpage>&#x02010;<lpage>16</lpage>, 18.</mixed-citation></ref><ref id="irv12670-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="irv12670-cit-0036">
<string-name>
<surname>Sellers</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Black</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Froman</surname>
<given-names>S</given-names>
</string-name>. <article-title>An outbreak of Asian influenza in tuberculous patients</article-title>. <source xml:lang="en">Dis Chest</source>. <year>1959</year>;<volume>36</volume>:<fpage>471</fpage>&#x02010;<lpage>477</lpage>.<pub-id pub-id-type="pmid">14444747</pub-id></mixed-citation></ref><ref id="irv12670-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="irv12670-cit-0037">
<string-name>
<surname>Bernard</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kreis</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Le Quang</surname>
<given-names>S</given-names>
</string-name>. <article-title>The influence of influenza on tuberculosis</article-title>. <source xml:lang="en">Bull Acad Nat Med</source>. <year>1962</year>;<volume>146</volume>(<issue>7/8</issue>):<fpage>139</fpage>&#x02010;<lpage>145</lpage>.<pub-id pub-id-type="pmid">13868007</pub-id></mixed-citation></ref><ref id="irv12670-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="irv12670-cit-0038">
<string-name>
<surname>Fl&#x000f3;rido</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Grima</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Gillis</surname>
<given-names>CM</given-names>
</string-name>, et al. <article-title>Influenza A virus infection impairs mycobacteria&#x02010;specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection</article-title>. <source xml:lang="en">J Immunol</source>. <year>2013</year>;<volume>191</volume>(<issue>1</issue>):<fpage>302</fpage>&#x02010;<lpage>311</lpage>.<pub-id pub-id-type="pmid">23698750</pub-id></mixed-citation></ref><ref id="irv12670-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="irv12670-cit-0039">
<string-name>
<surname>Redford</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Mayer&#x02010;Barber</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>McNab</surname>
<given-names>FW</given-names>
</string-name>, et al. <article-title>Influenza A virus impairs control of <italic>Mycobacterium tuberculosis</italic> coinfection through a Type I interferon receptor&#x02010;dependent pathway</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2014</year>;<volume>209</volume>(<issue>2</issue>):<fpage>270</fpage>&#x02010;<lpage>274</lpage>.<pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="irv12670-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="irv12670-cit-0040">
<string-name>
<surname>Massanari</surname>
<given-names>RM</given-names>
</string-name>. <article-title>Suppression of tuberculin hypersensitivity during influenza infection in mice</article-title>. <source xml:lang="en">Infect Immun</source>. <year>1979</year>;<volume>24</volume>(<issue>2</issue>):<fpage>501</fpage>&#x02010;<lpage>507</lpage>.<pub-id pub-id-type="pmid">457284</pub-id></mixed-citation></ref><ref id="irv12670-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="irv12670-cit-0041">
<string-name>
<surname>Co</surname>
<given-names>DO</given-names>
</string-name>, <string-name>
<surname>Hogan</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Karman</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Interactions between T cells responding to concurrent mycobacterial and influenza infections</article-title>. <source xml:lang="en">J Immunol</source>. <year>2006</year>;<volume>177</volume>(<issue>12</issue>):<fpage>8456</fpage>&#x02010;<lpage>8465</lpage>.<pub-id pub-id-type="pmid">17142743</pub-id></mixed-citation></ref><ref id="irv12670-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="irv12670-cit-0042">
<string-name>
<surname>Guarner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Falcon&#x02010;Escobedo</surname>
<given-names>R</given-names>
</string-name>. <article-title>Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses</article-title>. <source xml:lang="en">Arch Med Res</source>. <year>2009</year>;<volume>40</volume>(<issue>8</issue>):<fpage>655</fpage>&#x02010;<lpage>661</lpage>.<pub-id pub-id-type="pmid">20304252</pub-id></mixed-citation></ref><ref id="irv12670-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="irv12670-cit-0043">
<string-name>
<surname>Rabagliati</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Siri</surname>
<given-names>ZL</given-names>
</string-name>, <string-name>
<surname>P&#x000e9;rez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Labarca</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Ferr&#x000e9;s</surname>
<given-names>GM</given-names>
</string-name>. <article-title>[Pandemic influenza A (H1N1) 2009: epidemiology, clinical features and differences with seasonal influenza in Chile]</article-title>. <source xml:lang="en">Rev Chilena Infectol</source>. <year>2011</year>;<volume>28</volume>(<issue>6</issue>):<fpage>546</fpage>&#x02010;<lpage>553</lpage>.<pub-id pub-id-type="pmid">22286677</pub-id></mixed-citation></ref><ref id="irv12670-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="irv12670-cit-0044">
<string-name>
<surname>Reed</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chaves</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Perez</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2014</year>;<volume>59</volume>(<issue>2</issue>):<fpage>166</fpage>&#x02010;<lpage>174</lpage>.<pub-id pub-id-type="pmid">24785230</pub-id></mixed-citation></ref><ref id="irv12670-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="irv12670-cit-0045">
<string-name>
<surname>Lee</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lui</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?</article-title>
<source xml:lang="en">J Infect Dis</source>. <year>2011</year>;<volume>203</volume>(<issue>12</issue>):<fpage>1739</fpage>&#x02010;<lpage>1747</lpage>.<pub-id pub-id-type="pmid">21606532</pub-id></mixed-citation></ref><ref id="irv12670-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="irv12670-cit-0046">
<string-name>
<surname>Muthuri</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Venkatesan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Myles</surname>
<given-names>PR</given-names>
</string-name>, et al. <article-title>Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta&#x02010;analysis of individual participant data</article-title>. <source xml:lang="en">Lancet Respir Med</source>. <year>2014</year>;<volume>2</volume>(<issue>5</issue>):<fpage>395</fpage>&#x02010;<lpage>404</lpage>.<pub-id pub-id-type="pmid">24815805</pub-id></mixed-citation></ref><ref id="irv12670-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="irv12670-cit-0047">
<string-name>
<surname>Duque</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>McMorrow</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?</article-title>
<source xml:lang="en">BMC Public Health</source>. <year>2014</year>;<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>5</lpage>.<pub-id pub-id-type="pmid">24383435</pub-id></mixed-citation></ref><ref id="irv12670-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="irv12670-cit-0048">
<string-name>
<surname>Walaza</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>. <article-title>Recommendations pertaining to the use of influenza vaccines and influenza antiviral drugs: influenza 2015</article-title>. <source xml:lang="en">S Afr Med J</source>. <year>2015</year>;<volume>105</volume>(<issue>2</issue>):<fpage>90</fpage>.<pub-id pub-id-type="pmid">26242521</pub-id></mixed-citation></ref><ref id="irv12670-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="irv12670-cit-0049">
<string-name>
<surname>Seki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kosai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yanagihara</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Disease severity in patients with simultaneous influenza and bacterial pneumonia</article-title>. <source xml:lang="en">Intern Med</source>. <year>2007</year>;<volume>46</volume>(<issue>13</issue>):<fpage>953</fpage>&#x02010;<lpage>958</lpage>.<pub-id pub-id-type="pmid">17603232</pub-id></mixed-citation></ref><ref id="irv12670-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="irv12670-cit-0050">
<string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Moyes</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Severe influenza&#x02010;associated respiratory infection in high HIV prevalence setting, South Africa, 2009&#x02013;2011</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2013</year>;<volume>19</volume>(<issue>11</issue>):<fpage>1766</fpage>&#x02010;<lpage>1774</lpage>.<pub-id pub-id-type="pmid">24209781</pub-id></mixed-citation></ref><ref id="irv12670-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="irv12670-cit-0051">
<string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Moyes</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Mortality amongst patients with influenza&#x02010;associated severe acute respiratory illness, South Africa, 2009&#x02013;2013</article-title>. <source xml:lang="en">PLoS ONE</source>. <year>2015</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e0118884</fpage>.<pub-id pub-id-type="pmid">25786103</pub-id></mixed-citation></ref></ref-list></back></article>